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ABSTRACT 
 
 
The World Health Organisation estimated that in 2002 more than 13,772 000 
deaths in developing countries were caused by infections. This accounted for 
more than 45% of all deaths, making up 7 of the top 10 causes of death 
(World Health Organisation, 2004). Sub-Saharan Africa is the epicentre of the 
devastating HIV pandemic. The country leading with the highest HIV rate in 
the world is South Africa, with approximately 5.5 million people infected 
(UNAIDS, 2008; South Africa Country Progress Report, 2008). 
 
The development from HIV to AIDS progressively weakens the immune 
system, making the individual more susceptible to numerous infections, e.g. 
various forms of orofacial sepsis (Mindel, and Tenant-Flowers, 2001). HIV-
positive individuals are eighteen times more likely to become infected with 
community-acquired methicillin-resistant Staphylococcus aureus than the 
general population. (Crum-Cianflone et al., 2006). The management of sepsis 
is of great concern with regard to human morbidity and mortality, as well as 
its financial implications, especially in cases of antibiotic resistance (Kimleck 
et al., 1976; Panlilo et al., 1992; Kirkland et al., 1999). Currently, there is no 
published peer-reviewed literature assessing the impact of HIV on orofacial 
sepsis. 
 
This study aimed to assess the impact of HIV on orofacial sepsis, investigating 
the clinical and microbiological profiles of the population. These results were 
used as a guide in the adaptation of current treatment protocols. 
 
The study population consisted of patients with orofacial sepsis (requiring 
incision and drainage or admission) who were referred to the Maxillo-Facial  
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and Oral Surgery Units at either Groote Schuur or Tygerberg Hospitals. These 
patients were examined, diagnosed and treated as per standard protocol. The 
empiric antibiotic treatment was tailored according to microscopy and 
sensitivity results when it became available. The exclusion criteria of the study 
were refusal of HIV testing or unwillingness of patients to participate in the 
study. 
 
The ratio of HIV positive patients treated was much higher than the 
population prevalence (2.4:1.1). Odontogenic infections (71.11%), followed 
by septic jaw fractures (15.56%) were the most common causes of sepsis. The 
most common causative teeth were the mandibular posterior teeth (43.75%) 
(excluding the mandibular 3rd molars). The most common fascial spaces 
involved in the HIV positive group were the submandibular spaces (36%), 
followed by the submasseteric and canine spaces (27% each). In the HIV 
negative group, the buccal (41%) and submandibular spaces (33%) were the 
most common fascial spaces infected. 
 
The HIV negative group had the most multi-fascial space involvement, with 
35% having more than one fascial space involved. In comparison, the HIV 
positive group had only 18% involvement of more than one fascial space. This 
was also reflected by the HIV negative group, which included five cases of 
Ludwig’s Angina as compared to one case in the HIV positive group. 
 
The Gram Stain showed a predominance of Gram positive cocci for both the 
HIV positive and negative groups. Gram positive bacilli were significantly 
more prevalent in the HIV negative group (p = 0.0409). Pre-treatment 
antibiotics were associated with sterile abscesses in 20% of the cases. No 
growth on culture occurred only in the HIV negative group (statistically 
significant with p = 0.00488). 
vii 
 
 
 
 
  
A statistically significant increased length of admission was found for the 
cases with penicillin-resistant bacteria (Wicoxin Rank Sum Test p = 
0.0072). Penicillin resistance was found in 17.78% (8 cases) with ten strains 
of five types of bacteria (S. aureus, K. pneumonia, Enterobacter, E. coli, 
Alpha-haemolytic Streptococcus). Eight percent (5) of these cases were also 
resistant to co-amoxiclav®. 
 
 
In the HIV positive group the following trends (p>0.005) were found:  
• The average platelet counts of this group was 112.34 x108/L (lower 
than the HIV negative group);  
• The length of admission for the HIV positive group was slightly 
longer by 0.25 days even though this group had fewer fascial spaces 
infected;  
• A larger number of bacteria with penicillin-resistance was more 
prevalent in the HIV positive group (six resistant bacteria in four cases 
compared to four resistant bacteria in four cases). 
 
Greater numbers of orofacial infections were seen in HIV positive 
subjects relative to their population prevalence rates. Added to this, was 
the higher rate of antibiotic resistance and longer hospital admissions. 
These findings may warrant further investigation of the relationship 
between HIV positive and negative groups with regard to orofacial sepsis. 
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CHAPTER 1 
 
INTRODUCTION 
 
The World Health Organisation estimated that in 2002 more than 13,772 000 deaths 
in developing countries were caused by infections. This accounted for more than 45% 
of all deaths making up seven of the top ten causes of death. HIV–AIDS has been of 
the largest contributors, with an estimated mortality of 2,678 000 (World Health 
Organisation, 2004). 
 
Sub-Saharan Africa forms the epicentre of the HIV pandemic, making up 90% of all 
paediatric cases and 68% of all the adult cases of HIV (UNAIDS, 2008). With South 
Africa having approximately 5.5 million people infected with HIV, it has the highest 
rate in the world (UNAIDS, 2008; South Africa Country Progress Report, 2008 Key 
HIV Statistics, 2008). 
 
The progression from HIV to AIDS may take up to 10 years or more. It progressively 
weakens the immune system making the individual more susceptible to numerous 
infections, e.g. various forms of orofacial sepsis (Mindel and Tenant - Flowers, 
2001). 
 
Management of infections with antibiotics has revolutionised medicine, starting with 
the discovery of penicillin by Nobel laureate, Alexander Flemming. Soon after his 
revolutionary break through, he discovered that this ‘wonder drug’ had become 
ineffective against certain Staphylococcus strains. He then correctly predicted that 
antibiotic failure would result with imprudent usage. It is now an accepted fact that 
sub-therapeutic doses create a situation where highly resistant strains can be selected 
sequentially. 
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In recently published literature, it appeared that HIV positive individuals may have a 
greater risk of antibiotic resistance compared to their HIV negative controls (Cotton 
et al., 2008; Madhi et al, 2000; Krucke et al, 2008). In a prospective study by Cotton 
et al. (2008), nasopharyngeal swabs and blood cultures were done on 203 HIV 
positive children. The authors found that resistance to Trimethoprim 
Sulphamethoxazole (TMP-SMX) occurred in more than 80% of all pathogens except 
with M. cattarrhalis. Methicillin-resistant S. aureus was significantly associated with 
TMP-SMX treatment (p = 0.002). They also found that 50% of Entrobacteriaceae 
produced extended spectrum β-lactamases (ESBL), making them resistant to third 
generation cephalosporins, and 56% were resistant to gentamycin. MRSA (resistant 
to penicillin and oxacillin) occurred in 77% of S. aureus cases. It was concluded that 
HIV positive children were colonised with potential pathogens which were resistant 
to commonly used antibiotics, and that antibiotic prescribers should take cognisance 
of these resistance patterns. 
 
Krucke et al. (2008) conducted a study on adult HIV-infected individuals who 
developed cutaneous abscesses, and found that the most common microorganism was 
S. aureus (84.6%).  Methicillin-resistant S. aureus was found in 85.7% of cases, but 
these organisms were not resistant to TMP-SMX, rifampicin or vancomycin.  In the 
2006 publication by Crum-Cianflone, he found that HIV-positive individuals were 18 
times more likely to become infected with community-acquired methicillin-resistant 
S. aureus than the general population.  
 
The management of sepsis is of great concern with regard to human morbidity and 
mortality, as well as its financial implications, especially in cases of antibiotic 
resistance (Kirkland et al., 1999; Panlilo et al., 1992). Surveillance of antibiotic 
resistance against common causative organisms should be used to establish sensitivity 
profiles. The sensitivity profiles should be disease-based to inform the development 
of, or amendment to, standard treatment guidelines and essential drugs lists (Iruka et 
el., 2003). 
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In a 3-year retrospective study (Amaidas, 1990) conducted at one of the Maxillo-
Facial and Oral Surgery Referral Units in the Western Cape, it was found that 
cervicofacial sepsis made up 4% (587 patients) of admissions. In the author’s analysis 
of a randomly selected group (60 patients), he found two cases of antibiotic resistance 
to the first line antibiotics (amoxycillin or penicillin G and metronidazole). In both 
cases the bacteria was sensitive to ampicillin. This result does not appear to reflect 
the current antibiotic resistance profile as seen at the same Maxillo-Facial and Oral 
Surgery Unit and at its sister unit 20km away. It also appeared to that HIV positive 
patients presented with more odontogenic abscesses, and appeared to have more 
extensive abscess formation than the HIV negative population. Could HIV be the 
cause of increased antibiotic resistance? This could not be substantiated nor negated, 
as there is a sparsity of peer-reviewed publications dealing with orofacial sepsis 
comparing the HIV positive and HIV negative populations and their antibiotic 
resistance profiles.  
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 Types of Flora 
 
2.1.1 Normal Flora 
 
It is usually comprises of combinations of indigenous bacteria and yeasts specific to 
anatomical regions of the body. These play a protective role against pathogenic 
organisms. The composition, numbers, and the distribution is determined by the 
anatomic region, host’s immunity, oxygen and humidity levels, surface of the body 
and competition with other microbes (Koneman et al, 1988). The flora may change, 
be replaced by a transient flora, may return to normal flora or be changed 
permanently. 
 
2.1.2 Oral Flora 
 
The evolution of the oral flora begins at birth and is representative of the mother’s 
vagina, comprising of Enterococci, Streptococci and microaerophillic organisms 
(Koneman et al, 1988). Aerobic microflora predominate until eruption of teeth occur 
when the environment harbours more anaerobic flora. Diet, smoking, medication, 
alcohol, radiation and diseases (processes like caries and periodontal disease) all 
affect microflora composition (Koneman et al, 1988). The normal oral flora 
comprises of a combination of bacteria, fungi, yeasts, protozoa, spirochetes and 
viruses (Figure 1). 
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Figure 1.  
Some of the most common indigenous and colonising oral flora [Haug, 2003] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aerobic and facultative isolates   
Diphtheroids 
Lactobacilli 
Rothia dentocariosa 
Streptococcus faecalis 
Streptococcus milleri 
Streptococcus mitis 
Streptococcus mutans 
Streptococcus salivarius 
Streptococcus sanguis 
Anaerobic isolates 
Actinobacillus 
actinomycetemcomitans 
Actinomyces israelii 
Actinomyces naeslundii 
Actinomyces odontolyticus 
Actinomyces viscosus 
Bacteroides asaccharolyticus 
Bacteroides melaninogenicus 
Bacteroides oralis 
Bacteroides ochraceus 
Bacterionema matruchotii 
Branhamella catarrhalis 
Capnocytophaga gingivalis 
Capnocytophaga ochraceus 
Capnocytophaga sputigena 
Eikenella corrodens 
Fusobacterium plauti 
Fusobacterium nucleatum 
Neisseria sicca 
Peptostreptococcus 
Veillonella alcalescens 
Veillonella parvula 
Spirochetes 
Spirochaeta species 
Christispira species 
Treponema denticola 
Treponema orale 
Treponema macrodentium 
Treponema vincentii 
Borrelia species 
Leptospira species 
Yeasts 
Aspergillus species 
Candida albicans 
Other Candida species 
Geotrichum species 
Hemispora species 
Penicillium species 
Scopulariopsis species 
Viruses 
Herpes simplex virus 
Cytomegalovirus 
Protozoa 
Entamoeba gingivalis 
Trichomonas tenax 
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2.1.3 Cutaneous Flora 
 
The newborn’s flora is representative of the birth canal. It is replaced by a 
combination of aerobic and facultative anaerobic bacteria, yeasts and sometimes even 
animal-carried organisms (Schuster, 2002) (Figure 2). 
 
Figure 2.  
Some of the most common indigenous and colonising facial cutaneous flora 
[Haug, 2003] 
 
Aerobic and facultative isolates 
Acinetobacter species 
Enterobacteriaceae 
Corynebacterium species 
Micrococcus species 
Staphylococcus epidermidis 
Staphylococcus species 
Streptococcus viridans 
Yeasts 
Candida albicans 
Malassezia furfur 
Pityrosporum ovale 
Pityrosporum orbiculare 
Torulopsis glabrata 
Animal 
Demodex folliculorum 
 
 
 
2.1.4 Nasal and Paranasal Flora 
 
The nasal or paranasal sinuses are usually sterile at birth and become colonised by the 
environment it is exposed to (Bamberger, 1991). Nasal secretions contain enzymes 
and immunoglobulins that inhibit the growth of organisms, and may be colonised 
differently over time according to changed immunity of the host (Bamberger, 1991) 
(Figure 3). 
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Figure 3.  
Some of the most common indigenous and colonising nasal and paranasal sinus 
flora [Haug, 2003] 
 
Aerobic and facultative isolates 
Corynebacterium diptheria 
Corynebacterium species 
Haemophilus influenzae 
Haemophilus parainfluenza 
Neisseria species 
Staphylococcus species 
Streptococcus pneumoniae 
Moraxella species 
Micrococcus species 
Neisseria meningitidis 
Staphylococcus aureus 
Staphylococcus epidermidis 
Streptococcus viridans 
Streptococcus pneumonia 
Anaerobic isolates 
Propionibacterium acnes 
 
 
 
2.2 Major Causes of Orofacial Sepsis 
 
2.2.1 Odontogenic Causes 
 
In the early 1960s, teeth were listed as the fifth or sixth leading causes of death 
recorded on the London Bills of Mortality (Clarke, 1999). At the beginning of the 
twentieth century, dental infections were associated with a mortality rate of 10 -  40% 
(Turner-Thomas, 1908). 
 
Odontogenic bacterial infection is still reported as being the most common cause of 
orofacial sepsis.  This was illustrated by Amaidas (1990) who showed the prevalence 
of 56.7% for odontogenic only causes and 21.7%, where the tooth was left in the jaw 
line of fracture. 
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In a 4-year prospective study by Flynn et al. (2006a), they found that 65% of 
odontogenic abscesses were caused by caries, 22% by pericoronitis and 22% by 
periodontal infections. Other studies also supported the finding that odontogenic 
infections are the most common cause of orofacial sepsis (Woods, 1978; Morey et al., 
1984; Guralnick, 1984). 
 
With the improvement of laboratory protocols, the isolation of organisms has 
improved (Siqueira, 2001). The cultures from acute dental abscesses caused only by 
obligate anaerobes are approximately 20%. Depending on collection procedures, it 
may vary between 6 to 63% (Brook et al., 1991; Goumas et al., 1997; Khemaleelakul 
et al., 2002). Most cultures consist mostly of mixed obligate anaerobes and 
facultative anaerobes (59% to 75%), with obligate anaerobes outnumbering (1.5 to 
3:1) facultative anaerobes. The mean number of bacteria cultured from dentoalveolar 
abscesses is four with a range of 1 - 7.5 (Robertson and Smith, 2009). 
 
In the study of the causative bacteria in orofacial sepsis reviewed by Haug (2003), 
and the study of bacteria in non-ondontogenic sepsis reviewed by Robertson and 
Smith (2009), they agreed that the causative pathogens have not changed much. 
However, it is the reclassification and nomenclature changes, as well as improved 
sampling, better transport media, improved protocols and the standardisation of 
laboratories, which have led to more species being cultured and identified. 
 
The most commonly found facultative bacteria in abscesses are viridans Streptococci 
and anginosis Streptococci. The viridans group is subdivided into mutans, salivarus, 
sanguinis, mitis and oralis species. The anginosus group was previously identified as 
part of β-haemolytic Streptococci or they were divided as Streptococcus melleri or 
Streptococcus anginosus (Facklam, 2002). 
 
Staphylococcus has more recently been identified as a frequent coloniser of oral 
environments. In the past, it was not considered to play a major pathogenic role 
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(Smith et al., 2001). In the review article by Robertson and Smith (2009) it was found 
that S. aureus was identified in 0.7 to 15% of acute abscesses. However, in the 
publication by Mangundjaja and Hardjawinata, (1990) it was reported that S. aureus 
was found in 47% of cases.   In their review (Robertson and Smith, 2009), they also 
found that S. epidermidis was identified in up to 4 to 65% of cases. 
 
The most common anaerobes are fusobacteria and the pigment anaerobes, 
porphyromonas and Prevotella (Robertson and Smith, 2009). The analysis of the 
literature in this group is very difficult due to the taxonomic identification changes in 
this group. The Bacteriodes group is now subdivided into the sacchrolytic genus, 
Prevotella, and the asacchrolytic genus, Porhyromonas. A part of this group is still 
being identified as the Bacteriodes, namely fragilis and forsythus, with the latter 
being more commonly identified in dental abscesses. 
 
2.2.2 Trauma Related Causes 
 
Amaidas (1990), found that septic jaw fractures were the second most common cause 
of sepsis (21.7%). This was not unexpected, as the most common cause of admission 
to units in the Western Cape is trauma. 
 
With trauma, the skin and or mucosa protective barriers are breeched allowing 
bacteria into the subcutaneous tissues. This occurs either by exposure (fracture open 
to periodontal ligament space) or by direct inoculation (breech of skin due to 
contaminated foreign object or even directly due to human or animal bites). The 
location of the injury and mechanism of injury will often determine the flora that 
initiates the infections.  
 
The most common organisms in human bites are (aerobes) Streptococci, especially 
angionosus, Staphylococci, (anaerobes) Eikenella corrodeus, Prevotella and 
Fusobacterium (Talan et al., 1999). 
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According to the review by Talan et al. (1999), they found that Pasturella was the 
most common bacteria in both dog and cat bites (more in cat bites) and that 
anaerobes made up approximately 50% in dog bites and 60% in cat bites, with 
Fusobacterium nucleatum, Bacteroides tectum, Prevotella heporinolytica and several 
phorphymonas species being isolated. Rabies is also of concern, especially with wild 
animals or infected pet bites. 
 
With midfacial fractures, organisms causing sepsis originate commonly from the 
nasal or paranasal sinuses or from cutaneous flora (Figures 2 and 3). Contamination 
with foreign material or debris often results in gram negative anaerobic infections 
(Brennen et al., 1990). Contamination with soil can result in Clostridium tetani and 
Actinomyces infections. With contaminated fresh water, the most common causative 
pathogens are E. coli (sea water as well), V.  cholera or Aeromona hydrophilia. 
 
With burns, maceration, avulsion or myonecrosis, the most common organisms are 
mixed infections. These organisms are anaerobic in nature such as Clostridium 
perfringes, Bacteroides and Prevotella together with Streptococci (Skitarelic et al., 
2003). 
 
Nosocomial infection is a great concern and occurs more often in immune- 
compromised patients and systemically ill patients. This is due to the high incidence 
of multi-drug resistant organisms in these patients. Staphylococcus aureus, 
Enterococci, Klebsiella and Mycobacterium tuberculosis are the most common 
pathogenic, fastidious multi-drug resistant organisms identified, with differing 
patterns in each hospital, (organism types and drug resistance profiles) (Kirkland et 
al., 1999). 
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2.2.3 Nasal and Paranasal (Non-trauma Related) Causes 
 
Sinusitis is often divided into acute and chronic maxillary sinusitis, infective rhinitis, 
frontal and sphenoid sinusitis. This is due to the differences in management and 
causative organisms. Maxillary sinusitis is divided into acute community-acquired 
bacterial sinusitis (ACABS), chronic and nosocomial sinusitis (Winther et al., 1998). 
 
The most common organisms causing ACABS are S. pneumonia and H. influenza 
(approximately 50% of cases). Staphylococcus aureus, haemolytic Streptococci, M. 
catarhalis, Streptococcus species and anaerobic bacteria are also identified.  
 
The role of viruses in ACABS can be up to 40% but is usually about 25% of cases 
(Gwaltney, 2000). According to Winther (1998), the organisms causing ACABS have 
remained unchanged except for their antibiotic resistance profiles. The resistance 
profiles are often geographic in nature with penicillin-resistant S. aureus, β–lactum 
resistant M. catarrhalis, H. influenza, as well as numerous strains of resistant S. 
pneumonia present. Often these strains form chronic sinusitis due to incorrect 
antibiotic management. 
 
Infectious rhinitis is classified into acute, self-limiting and chronic. The most 
common causes are rhinoviruses, influenza and parainfluenza viruses, creating a 
‘common cold’ as part of the disease. Bacterial and fungal causes are not very 
common. In patients with weak immune systems, the following unusual pathogens 
can be found: M. tuberculosis, aspergillosis, mucormycosis, syphilis, other fungi, 
protozoa and atypical mycobacteria (Winther, 1998). 
 
Frontal or sphenoid sinusitis is uncommon (< 5%) and have a significant morbidity 
associated. They are often caused by resistant strains of S. aureus, S. pneumonia and 
H.  influenza. The frontal, sphenoid and chronic maxillary sinus infections are often 
surgically managed (Winther, 1998). 
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2.3 Cutaneous Infections 
 
Cutaneous infections can be subdivided into bacterial, fungal, protozoal and viral 
causes. The most common bacterial cause is folliculitis, consisting of itchy, tender 
papules or pustules. This infection of the hair follicle may be superficial or deep, with 
infected follicle hair removed easily. The bearded area is normally involved (sycosis 
barbae) in subjects with stiff, curly beard hairs that re-enter the skin. Causative 
organisms are usually S. aureus, C. albicans and P. aeruginosa. Deeper seated, 
infected furuncles are usually caused by Staphylococci, occurring most frequently on 
the neck, breasts, face and buttocks. It begins as a nodule that becomes a pustule five 
to 30mm in size and develops central necrosis with discharge of necrotic core and 
purulent fluid. Small outbreaks may be common (furunculosis) in healthy individuals 
living together in poor hygiene conditions. Carbuncles are the more severe form and 
consist of clusters of furuncles with subcutaneous spread of pus, causing sloughing 
and slow healing scars. Carbuncles are often accompanied by systemic symptoms. 
All these conditions require antibiotic therapy, but folliculitis may also require topical 
fusidic acid application. Surgical drainage and sensitivity testing is also 
recommended for furunculosis and carbuncles (Kumar and Clarke, 1998). 
 
2.3.1 Erysipelas 
 
Erysipelas is a condition that mimics cellulitis, primarily in young and elderly or 
diabetic patients. It is a superficial infection, which is commonly caused by β–
haemolytic Streptococci Group A, and less often by the other Streptococci groups. 
Other bacteria associated are S. aureus, Pneumococcus, K. pneumonia, Y. enterlitica 
and H. influenza. The infection spreads via lymphatic channels giving the 
characteristic, fiery red face, which is well circumscribed, swollen, painful and 
indurated to touch. Penicillin is the mainstay of treatment. Complications from this 
condition vary from abscess formation, necrotising fasciitis, toxic shock syndrome, 
thrombophlebitis, acute glomerulonephritis, endocarditis, multi organ failure and 
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death. Recurrence of infections (erysipelas) is prone to damage lymphatics (Kumar 
and Clarke, 1998). 
 
2.3.2 Tuberculosis 
 
Tuberculosis in the orofacial region often manifests as a lymphadenitis, which may 
then breakdown with abscess and fistula formation (scrofula). It may also manifest as 
osteomyelitis with varying amounts of suppuration, often affecting the vertebrae or 
mandible. Virtually any system may be affected by tuberculosis including skin (lupus 
vulgaris), parotid gland, oesophagus, mucosa and middle ear. These forms of 
extrapulmonary tuberculosis are often associated with HIV-AIDS (50% will have 
extrapulmonary tuberculosis). Non-tuberculosis mycobacterial disease (M. bovis) 
from non-pasteurised, infected milk and M. avium-intercellulare, may often also 
cause lymphadenitis but can affect any organ system. Management is drainage of 
suppurative collections, debridement of necrotic bone (osteomyelitis) and 
antituberculosis antibiotics after microscopy and culture (Cleary and Batsakis, 1995). 
 
2.3.3 Gonorrhoea 
 
Gonnorrhoeae is primarily a sexually transmitted disease but can affect the orofacial 
region after septicemic dissemination or directly via oral sex. The oropharynx 
demonstrates oedema and erythema with small punctuate pustules. It is caused by the 
sacchrolytic gram negative diplococci, N. gonorrhoeae. Treatment recommendation is 
the ‘syndromic’ approach for sexually transmitted diseases (Department of Health) 
due to the likelihood of multiple resistant pathogens. Partners should also be treated. 
The antibiotic combination would then cover all pathogens causing the same 
symptoms, e.g. N. gonorrhoeae and C. trachomatis. A single dose of either 
cefotaxime 1g intramuscularly; ceftriaxone 250 mg intramuscularly; ciprofloxacin 
500mg orally; ofloxacin 400mg orally for 7 days; minocycline 100mg 12 hourly for 7 
days or azithromycin 1g orally as a single dose, is advocated. 
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2.3.4 Necrotising Stomatitis (Cancrum Oris) 
 
Necrotising stomatitis or noma, is a rapidly progressive infection in malnourished, 
immune compromised patients living in a poor hygiene environment. It is often 
preceded by other infections like measles, tuberculosis, herpes simplex, varicella and 
bronchopneumonia. Some authors believe it begins with necrotising ulcerative 
gingivitis (ANUG). It is caused by a mixed infection usually comprising of F. 
necrophorum, F. nucleatum, P. intermedia, B. vincentii, S. aureus and non-
haemolytic Streptococci species. A related disorder, noma neonatorum, arises in low 
birth weight infants, usually in the first month of gestation. The organisms causing 
the paediatric form of disease, almost always consist of P. aeruginosa, often with E. 
coli, Klebsiella or Staphylococcal species (Falkler et al., 1999). 
 
2.3.5 Actinomycosis 
 
Actinomycosis often affects the orofacial region (55%), 25% occurring in the 
abdominal and pelvic regions, 15% in the pulmonary system and 5% in the skin and 
genitourinary system. The infection may be acute, rapidly progressive or may be 
chronic in nature. It characteristically gives a suppurative infection with discharging 
yellow granules (called sulphur granules) which represent colonies of the gram 
positive anaerobic filamentous branching pathogen. It usually begins in an area of 
trauma or a previous extraction site. It then spreads typically, not following fascial 
planes, rather by direct extension and often forms numerous sinus tracts. Salivary 
gland and actinomycetic osteomyelitis is not unusual and often presents with very 
little pain. On microscopy, club–shaped filaments radiating in a rosette pattern with 
characteristic eosinohyllic periphery and basophyllic core (haematoxylin and eosin 
stain), can be seen. Long-term penicillin is the drug of choice (Miller and Haddad, 
1998). 
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2.3.6 Cat–scratch disease 
 
Cat–scratch disease presents as a papule or pustule at the site of a cat bite or scratch 
that forms three to 14 days after the injury. It usually heals by the time the 
lymphadenitis forms (draining node/s). Complications are suppuration, conjunctival 
granuloma (periorbital lesion), and temporary facial paralysis if the lymphoid tissues 
of the parotid gland is affected. Microscopy is required to identify the zonotic 
bacillary pathogen Bartonella henselae. The antibiotics of choice are doxycycline and 
erythromycin showing dramatic recovery in two days. 
 
2.3.7 Acute Suppurative Lympadenitis 
 
Acute suppurative lympadenitis most commonly occurs in children under four years 
old. This, according to Butler and Baker (1992), is due to the inability of the younger 
child’s immune system to localise the organism at the site of attachment to the nasal 
or pharyngeal epithelium, allowing spread to nodes and resulting in suppuration. The 
most commonly affected nodes are the jugulodigastric and submandibular nodes. The 
most common causative organisms are S. aureus, S. pyogenes, with anaerobic 
organisms like porphyromonas and Bacteroides (Brook, 1987). Other bacteria like 
tuberculosis and atypical tuberculosis (M. avium intracellulare) also occur. 
According to Butler and Baker (1992) and Nuss and Cunningham (1993), HIV should 
also be regarded as an etiological agent. Management is incision and drainage if a 
collection is present and intravenous cloxacillin and metronidazole is recommended 
according to population resistance profiles. 
 
2.3.8 Necrotising Fasciitis 
 
Necrotising fasciitis is a life threatening, rapidly spreading polymicrobial infection 
which causes oedema and necrosis of the fascia and subcutaneous tissues. The 
initiating cause of the infection is often minor trauma with contiguous spread of 
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infection like an abscess. This often occurs in individuals who are diabetic, alcoholic, 
immune suppressed (including HIV) and medically compromised.  The most 
commonly affected regions are the extremities as well as the perineum, abdomen and 
head and neck regions. When the male genitalia are involved, it is called Fournier’s 
disease. This disease begins with a very painful, red, hot and swollen skin and the 
patient displays signs and symptoms of systemic toxicity (high fever or hypothermia, 
tachycardia, hypotension, tachypnoea, hypoxemia, oliguria and often encountered, 
altered mental state). With progression, a volacious hue appears on the skin with the 
development of bullae or vesicles. Soon thereafter, the skin becomes anaesthetised 
with the development of frank necrosis. Microbiological analysis shows the 
occurrence of numerous species of Group A β – haemolytic Streptococci, as well as 
Prevotella or Bacteroides. In some cases Clostridia species can also be found. 
 
Management requires intensive care admission with broad spectrum antibiotics, 
repeated aggressive surgical debridement (up to bleeding skin margins), antiseptic 
wound packing, intensive medical support, including fluid electrolytes and even 
blood products if required (Balcerak et al., 1988). Hyperbaric oxygen may also be of 
benefit to these patients (Langford et al., 1995). 
 
2.3.9 Herpes Simplex Infection 
 
Herpes Simplex infection is considered as one of the most common infections of the 
orofacial region affecting mucocutaneuos regions of mostly the face and mouth, but 
can also affect the nasal and conjunctival structures. This lesion is rarely the cause of 
sepsis in the non-compromised host. HIV, organ transplant and malnourished 
individuals are susceptible to widespread and repeated infection associated with 
septic and possible orbital complications. Other complications that may occur in 
immune-compromised or susceptible groups, are herpetic witlow (infection of 
fingers), and herpes gladiatorum (infection of abraded skin lesions) (Neville et al., 
2002). 
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2.3.10 Osteomyelitis 
 
Osteomyelitis is an infectious process in malnourished or immune suppressed 
individuals causing an acute or chronic inflammatory process of the medullary and/or 
cortical surfaces of bone. There are several patterns identified other than the acute or 
chronic forms, namely focal and diffuse sclerosing osteomyelitis, proliferative 
periostitis and alveolar osteitis (Neville et al., 2002). 
 
The most common precipitating causes are odontogenic infection and traumatic 
fracture of jaws. Other causes, often seen in developed countries, include acute 
necrotising gingivitis (ANUG) and cancrum oris (noma) (Adekeye and Cornah, 
1985). The management of acute osteomyelitis is intravenous antibiotics and 
drainage. The antibiotics in acute osteomyelitis must cover odontogenic organisms. 
S. aureus and Salmonella often cause acute osteomyelitis in sickle cell disease. In 
cases of chronic osteomyelitis, S. aureus and Salmonella, with the addition of β – 
haemolytic Streptococcus and even sometimes actinomyces, are often identified as 
causative pathogens. (Flynn; Halpern, 2003). 
 
2.3.11 Uncommon Causes 
 
Other causes, that are unlikely to form purulent infection, are cutaneous rhizopus, 
fungal infections (histoplasmosis, blastomycosis, candida, aspergilosis, and 
leptospirosis caused by Leptospira species) and Bubonic plague caused by Y. pestis. 
 
2.4 Spread of Infection 
 
As odontogenic infection has been shown to be the most common cause of abscess 
formation (Chow et al., 1978; Woods, 1978; Guralnick, 1984; Amaidas, 1990; Flynn 
et al, 2006a), the mechanisms and principles of spread of infection will be illustrated 
using odontogenic origins. The causes of odontogenic infection are most commonly 
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from carious teeth, pericoronitis, periodontitis, dentoalveolar or jaw fractures with 
teeth in the fracture line and exodontia (usually post surgical). Less common causes 
reported are loose implants (plates, screws and wires), septic grafts (jaw 
augmentation) and needle tract sepsis (post local anaesthetic). 
 
According to Chavez de Paz (2007), after the pulp chamber is breached (carious 
tooth), a mixed bacterial colony is formed. This causes the wall of the root canal to 
become colonised by a special mixed anaerobic biofilm. Abscess formation occurs 
when bacteria and toxic products enter the periapical tissues via the apical foramen. 
Asymptomatic necrosis of the pulp may occur, but when periapical spread has 
occurred, symptoms manifest (pain, swelling, erythema).  
 
After infection has occurred, it may remain localised or it may spread. The main 
routes of propagation are via haematogenous, lymphatic or by direct continuity 
(contiguous spread) (Shafer et al, 1983). Direct continuity is the propagation of the 
infection along anatomic pathways of least resistance (between fascia layers) (Bartlett 
and Gorbach, 1976). 
 
Roots of the teeth close to the buccal cortical plate generally spread purulent material 
buccally, while those close to the lingual or cortical plate, or maxillary sinus, 
generally spread to those closely associated structures. This may lead to the formation 
of a dentoalveolar abscess or sinusitis. The abscess may localise and form a fistulous 
tract (mucosa or skin) or may spread through fascial planes forming abscess 
collections in potential anatomic spaces (Killey et al., 1975). (Figure 4. A and 4. B) 
by Chow et al., 1978). 
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Figure 4. Routes of spread of odontogenic orofacial infections along planes of 
least resistance.  
 
 
 
 
 
Figure 4. (A) Coronal section in region of first molar teeth.  
a = maxillary antrum; b = nasal cavity; c = palatal plate; d = sublingual space (above 
mylohyoid muscle); e =submandibular space (below mylohyoid muscle); 
f = intraoral presentation with infection spreading through the buccal plates inside the 
attachment of the buccinator muscle: g = extraoral presentation to buccal space with 
infection spreading through the buccal plates outside the attachment of the buccinator 
muscle (Chow et al., 1978).
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Figure 4. (B).Lingual aspect of the mandible, a = apices of involved tooth above the 
mylohyoid muscle, with spread of infection into sublingual space; b = apices of 
involved tooth below the mylohyoid muscle, with spread of infection into 
submandibular space  (Chow et al., 1978). 
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Table 1: Borders of the Deep Spaces of the Head and Neck    
Borders 
Space Anterior  Posterior Superior Inferior Superficial or  Medial* Deep or Lateral† 
Buccal Corner of mouth  Masseter m.,  Maxilla,  Mandible  Subcutaneous  Buccinator m. 
   pterygomandibular  infraorbital space  tissue and skin   
   Space     
Infraorbital Nasal cartilages Buccal space Quadratus labii  Oral mucosa Quadratus labii  Levator anguli oris m., 
      superioris m.   superioris m. maxilla 
Submandibular  Ant.belly Post. Belly Inf.and med. Digastric tendon  Platysma m., Mylohyoid, 
   digastric m.  digastric,  surfaces of    investing fascia   hyoglossus 
   stylohyoid,  Mandible    sup. constrictor mm 
   stylopharyngeus mm.     
Submental Inf. border of Hyoid bone Mylohyoid m. Investing fascia Investing fascia  Ant. bellies 
   mandible      digastric m.† 
Sublingual Lingual surface of  Submandibular  Oral mucosa Mylohyoid m. Muscles of tongue* Lingual surface of 
  mandible  Space     mandible† 
Pterygomandibular  Buccal space Parotid gland  Lateral Inf. border of Med. Pterygoid Ascending ramus of 
     pterygoid m.  mandible   muscle*  mandible† 
Submasseteric Buccal space Parotid gland Zygomatic arch Inf. border of  Ascending ramus Masseter m.† 
       mandible  of mandible*  
Lateral pharyngeal  Sup. and mid.  Carotid sheath Skull base Hyoid bone Pharyngeal  Medial pterygoid m.† 
    pharyngeal   and scalene fascia    constrictors and  
      constrictor mm.      Retropharyngeal  
       space*  
Retropharyngeal  Sup. and mid. Alar fascia   Skull base Fusion of alar and  —  Carotid sheath and 
   pharyngeal    prevertebral fasciae   lateral pharyngeal 
  constrictor mm.    at C6-T4   space† 
Pretracheal  Sternothyroid-  Retropharyngeal  Thyroid cartilage Superior Sternothyroid- Visceral fascia over 
  thyrohyoid fascia  space    mediastinum  thyrohyoid fascia  trachea and thyroid 
         gland 
Peterson  et al.  adapted from Flynn.,2003      
ant. = anterior; inf. = inferior; lat. = lateral; m. = muscle; mm. = muscles; med. = medial; mid. = middle; post. = posterior; sup. = superior.  
*Medial border; †lateral border. 
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Table 2: Relations of Deep Spaces in Infections   
Space  Likely Causes  Contents Neighboring  Spaces Approach for Incision and Drainage 
Buccal Upper bicuspids Parotid duct  Infraorbital Intraoral (small) 
  Upper molars  Ant. facial a. and v. Pterygomandibular Extraoral (large) 
  Lower bicuspids Transverse facial a. and v.  Infratemporal   
    Buccal fat pad     
Infraorbital  Upper cuspid Angular a. and v.  Buccal Intraoral 
    Infraorbital n.     
Submandibular Lower molars Submandibular gland  Sublingual  Extraoral 
   Facial a. and v. Submental   
   Lymph nodes Lateral pharyngeal   
      Buccal   
Submental  Lower anteriors Ant. Jugular v. Submandibular  Extraoral 
   Fracture of symphysis  Lymph nodes  (on either side)   
Sublingual Lower bicuspids Sublingual glands Submandibular  Intraoral 
   Lower molars Wharton’s ducts Lateral pharyngeal Intraoral-extraoral 
  Direct trauma Lingual n. Visceral (trachea and   
    Sublingual a. and v.  esophagus)   
Pterygomandibular  Lower third molars Mandibular div. of Buccal  Intraoral 
  Fracture of angle of  trigeminal n. Lateral pharyngeal Intraoral-extraoral 
  Mandible Inf. Alveolar a. and v.  Submasseteric   
    Deep temporal   
      Parotid   
       Peritonsillar   
Submasseteric Lower third molars  Masseteric a. and v. Buccal  Intraoral 
  Fracture of angle of   Pterygomandibular  Intraoral-extraoral 
  mandible   Superf. temporal   
      Parotid   
Infratemporal and Upper molars  Pterygoid plexus Buccal  Intraoral 
deep temporal  Internal maxillary a. and v. Superf. temporal Extraoral 
   Mandibular div. of trigeminal n.  Inf. petrosal sinus Intraoral-extraoral 
    Skull base foramina     
Superfical 
temporal Upper molars Temporal fat pad  Buccal  Intraoral 
  Lower molars Temporal branch of facial n. Deep temporal  Extraoral 
        Intraoral-extraoral 
Lateral pharyngeal Lower third molars Carotid a.  Pterygomandibular  Intraoral 
   Tonsillar infection in Internal jugular v. Submandibular  Intraoral-extraoral 
  neighbouring spaces  Vagus n. Sublingual   
   Cervical sympathetic chain Peritonsillar   
      Retropharyngeal   
Peterson et al. adapted from Flynn .,2003  a = artery; div. =division; inf. = inferior; n = nerve; superf. = superficial; v = vein. 
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The propagation of periapical infection can normally be predicted as it usually 
follows a typical pattern. In the maxilla, periapical infections associated with the 
roots of the anterior teeth and the buccal roots of the posterior teeth drain labially and 
buccally respectively. Infections associated with the palatal roots of the posterior 
teeth drain palatally. Occasionally, if the root apices are in approximation to the 
maxillary sinus, sinus spread may occur. In adults, the premolar and molar apices are 
often inferior to the buccinator muscle attachment, localising the abscess intraorally. 
In children, the apices are higher in relation (buccinator) and therefore spread 
superiorly (canine space). 
 
Mandibular incisors or canine infection commonly spread labially (thinner cortex). If 
apices are superior to the mentalis muscle insertion, it will spread intraorally and if it 
is below the muscle, extraoral spread is possible. Mandibular premolars and molars 
often perforate buccally, whereas second and third molars mostly perforate lingually. 
 
Figure 5 illustrates the possible spread of infection to the sublingual and 
submandibular spaces determined by the relationship of root apices to the mylohyoid 
muscle. 
 
Figure 5. Incision placement for extraoral drainage of head and neck infections. Incisions at the 
following points may be used to drain infections in the indicated spaces: superficial and deep temporal, 
submasseteric; submandibular, submental, sublingual; submandibular, sublingual, pterygomandibular, 
submasseteric; lateral pharyngeal, retropharyngeal; lateral pharyngeal, retropharyngeal, carotid sheath. 
(Peterson et al. 2003, adapted from Flynn). 
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2.5 Management 
 
Peterson et al. (2003) describes eight steps in the management of odontogenic 
infections. This is a thorough, logical and scientifically sound approach and therefore 
this format will be adopted in the critical analysis of literature in this section. 
 
The eight steps are: 
1. Determine the severity of the infection 
2. Evaluate host defenses 
3. Decide on setting of care 
4. Treat surgically 
5. Support medically 
6. Choose and prescribe antibiotic therapy 
7. Administer the antibiotic properly 
8. Evaluate the patient frequently 
 
2.5.1 Determine the Severity of Infection 
 
A history and thorough examination will allow the surgeon to assess the severity of 
the infection, by assessing the anatomic space/s involved, the possibility of airway 
compromise, the rate of progression and to what measure systemic reserves and 
homeostasis is being challenged. 
 
Flynn et al. (1999) created a scoring system to assess the severity of airway 
compromise. He divided the anatomic locations into low, moderate, severe and 
extremely severe and scored each from one to four with increasing severity (Table 3). 
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Table 3: Severity Scores of Fascial Space Infections 
  
Severity Score Anatomic Space 
  
Severity score = 1 Vestibular 
(low risk to airway or vital structures) Subperiosteal 
 Space of the body of the mandible 
 Infraorbital 
 Buccal 
Severity score = 2  Submandibular 
(moderate risk to airway or vital structures)  Submental 
 Sublingual 
 Pterygomandibular 
 Submasseteric 
 Superficial temporal 
 Deep temporal (or infratemporal) 
Severity score = 3  Lateral pharyngeal 
(high risk to airway or vital structures)  Retropharyngeal 
 Pretracheal 
Severity score = 4  Danger space (space 4) 
(extreme risk to airway or vital structures)  Mediastinum 
 Intracranial infection 
The severity score for a given patient is the sum of the severity scores for all of the spaces involved by cellulitis or abscess, 
based on clinical and radiographic examination.  Flynn et al.,1999. 
 
 
Using this scoring system together with the initial white cell count, Flynn et al. 
(1999) were able to predict the length of stay in hospital in 66% of cases. The rate of 
progression would be obtained by history and current examination. The causes that 
were found to be rapidly progressive would negate a more aggressive management. 
In an analysis by these authors, they also found that there was a negative correlation 
between severity and number of days prior to consultation, confirming that rapidly 
progressing cases presented sooner than slowly progressing cases. 
 
Airway compromise is a major cause of death in severe odontogenic infections. In a 
study by Williams (1940), a 54% mortality rate was reported, which was later 
reduced to 10% (Williams and Guralnick, 1943). This was achieved by ensuring 
airway safety and aggressive surgical drainage of all spaces; this in a pre–antibiotic 
era. 
 
The mortality rate was reported to be above 4% for Ludwig’s angina (Haug et al., 
1980). With airway compromise caused by deep fascial space infection, intubating 
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the patient is extremely difficult despite fibre-optic assisted intubation. Often 
emergency airway procedures like cricothyroidotomy or tracheostomy are required. 
This is sometimes done through a septic collection in the neck to secure an airway. 
Indications for tracheostomy are listed in Figure 6. 
 
 
On clinical examination of a patient with airway compromise, stridor may be heard. 
The patient may assume an upright or slightly forward posture with chin tilted up, 
and may gasp or may be unable to breathe when lying flat. It is standard practice in 
our units to assess all severe cases by sitting the patient upright and slowly lowering 
the backrest of the chair towards a flat position. By doing this, we can often assess the 
severity of airway occlusion, where those with impending occlusion will have 
difficulty breathing in the position slightly tilted back or even in the upright position. 
Figure 6. Indications for tracheostomy [Pryor et al., 2000] 
• To relieve upper airway obstruction  
• Foreign body  
• Trauma  
• Acute infection - acute epiglottitis, diphtheria, Ludwig’s 
Angina  
• Glottic oedema  
• Bilateral abductor paralysis of the vocal cords  
• Tumours of the larynx  
• Congenital web or atresia  
• To improve respiratory function  
• Fulminating bronchopneumonia  
• Chronic bronchitis and emphysema  
• Chest injury and flail chest  
• Respiratory paralysis  
• Unconscious head injury  
• Bulbar poliomyelitis  
• Tetanus  
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Airway compromise can be assessed via radiographs of the lateral neck and CT scans. 
A clinical examination may give a good indication of the risk of airway compromise. 
Severe involvement is seen when the floor of mouth is raised and ‘full’ (indurated 
with lifting or without fluctuance, displacing the tongue posteriorly). Other locations 
of severe airway compromise are found when the tonsillar pillar is edematous and 
swollen with or without uvula displacement, when the lateral pharyngeal space 
(lingual surface of mandible posterior to the third molar) is tender or edematous and 
the patient cannot swallow. 
 
2.5.2 Evaluating Host Defenses 
 
Many diseases and treatments (steroid, radiotherapy, chemotherapy) compromise the 
immune system. These patients are more prone to infection and often of a more 
severe nature (Neville et al., 2002). It is therefore recommended that more aggressive 
management be instituted to facilitate earlier recovery. Figure 7 shows a list of factors 
associated with immune compromise (Miloro, 2004). 
 
 
 
The systemic reserve of the host is determined by the age (limited reserves in young 
and old), nutritional state, state of health prior to infection, chronosity of infection 
Figure 7. Factors associated with immune system compromise [Peterson et al. 
2003]  
 
• Diabetes 
• Steroid therapy 
• Organ transplants 
• Malignancy 
• Chemotherapy 
• Chronic renal disease 
• Malnutrition 
• Alcoholism 
• End-stage AIDS 
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and the magnitude of the infection. These are the main factors assisting the host to 
survive. 
 
2.5.3 Deciding on Setting of Care 
 
Miloro et al. (2004) suggested six factors to warrant hospital admission (Figure 8). 
The author would also like to suggest the addition of another indication for 
admission, namely poor systemic reserves. In the developing world, patients with 
poor systemic reserves often encounted. These patients may develop small infections 
with no toxic symptoms (not threatening airway), and may not require IV antibiotics. 
Unfortunately due to poor natural reserves or chronic infections (TB commonly), 
their recovery will be poor with increased risk of complications. Often, they have to 
be treated surgically for the complications. With admission on IV antibiotics, their 
rate of recovery and risk of complications will be reduced. Comprehensive primary 
management is better than re-treatment of progressive disease or complications 
thereof. 
 
 
Patients with severe illness may be unable to maintain organ or system function. When 
organ failure occurs, it must be identified (Figure 9) and managed expeditiously. This 
includes surgical treatment (eliminate cause) and appropriate supportive medical 
management (high-care or intensive care). Figure 10 provides a brief summary of 
indications for intensive care admission (McIntosh, 2002). 
Figure 8. Indications for Hospital Admission [Miloro et al., 2004] 
 
• Temperature >38.3ºC 
• Dehydration 
• Threat to airway or vital structures 
• Infection in moderate or high severity anatomic spaces 
• Need for general anaesthesia 
• Need for in patient control for systemic disease 
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2.5.4 Treat Surgically 
 
Airway security is the primary concern, followed by removal of the cause and 
definitive drainage. A thorough knowledge of anatomy, appropriately made incisions 
and blunt dissection will allow complete evacuation of all affected fascial spaces. 
(Figures 5 and 11). 
 
Figure 9. Indications for ICU Admission 
• Mechanical support of organ function 
• Respiratory  - ventilation / CPAP 
• Renal  - haemofiltration / haemodialysis 
• Cardiac - ECG monitoring and inotropic support 
• Hepatic - blood transfusion 
• Neurological - intracranial pressure monitoring 
• Usually has 1:1 nursing care 
Figure 10. Factors Indicating Severe Organ Dysfunction or Pending Organ Failure 
[McIntosh, 2002] 
• Threatened airway  
• Respiratory arrest  
• Respiratory rate >40 or <8 breaths / min  
• Oxygen saturation <90% on >50% oxygen  
• Cardiac arrest  
• Pulse rate <40 or >140 beats / min  
• Systolic blood pressure < 90 mmHg  
• Sudden fall in level of consciousness  
• Repeated or prolonged seizures  
• Rising arterial carbon dioxide tension with respiratory acidosis  
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Figure 11. Intraoral incision placement for drainage of the anterior compartment of 
the lateral pharyngeal space (curved arrow) and the pterygomandibular space (straight 
arrow). (Peterson et al. 2003, adapted from Flynn). 
 
Incision and drainage should be achieved with the protection of all vital structures 
and gravity-assisted drainage should be created wherever possible. Incisions should 
be planned within relaxed tension lines of the neck or face. The use of through-and-
through drainage is often used for the provision of two pathways for the evacuation of 
pus, and efficient, unidirectional flow during irrigation. 
 
A few decades ago, patients were first placed on antibiotics to ‘localise’ the abscess 
prior to extraction and incision and drainage (Piecuch, 1962). 
 
In a landmark study of its time, Krogh (1951), in a sample of 2626, found only a 3% 
complication rate when the offending tooth was removed at initial presentation. Hall 
et al. (1968) published a study of 350 patients with odontogenic cellulitis that were 
divided into two groups. The one group had extractions on the day of presentation, 
and in the second group, antibiotic treatment was given to ‘localise the infection’. 
The offending tooth was then extracted on the fourth day. The finding was that both 
groups had no spread of cellulitis, however, the group receiving extractions on the 
day of presentation recovered more rapidly than the group with delayed treatment. 
The author also found that the second group (delayed treatment group), was twice as 
likely to require extra-oral incision and drainage. Therefore, early management not 
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only gives early relief of symptoms, but a 97% chance of cure as well. The ‘watchful 
waiting’ theory telling patients to return when the swelling has gone, is therefore 
antiquated and without sound basis. 
 
Culture and sensitivity testing, according to Miloro (2004), should not be done for 
minor oral infections as empiric antibiotic therapy is usually successful. It would be 
difficult to justify the additional costs of time-consuming microbiological tests when 
resolution of infection is obtained prior to results (sensitivity). It is generally accepted 
that microbiological testing is done for infections that are serious enough to warrant 
admission, or where immune compromise and chronic infections are recalcitrant to 
therapy. 
 
2.5.5 Support Medically 
 
Medical supportive care is essential with severe odontogenic infections, comprising 
of hydration, nutrition, and control of fever (Miloro, 2004). This author advocated 
adding active management for the prevention of deep venous thrombosis (below knee 
pressure stockings, medical management and early mobilisation), prevention of 
bedsores (early mobilisation, moisturising skin and good bed hygiene) and prevention 
of stomach ulceration (early feeding and medical management), all managed 
according to the risk- benefit (including cost) rationale and assessed individually. 
 
Initial temperature has shown to be a significant predictor of length of hospital stay in 
severe odontogenic infections (Flynn et al. 1999). It is known that fever below 39.4º 
C promotes phagocytosis, increases blood flow to affected areas, raises metabolic rate 
and enhances antibody functioning. Very high fever (> 39.4º C) drives the body to a 
catabolic state, depleting reserves and making immune and metabolic functions less 
effective. Therefore, temperature must be managed either medically (paracetamol, 
aspirin, acetamorphine) or with local measures like cool IV infusions, tepid sponge, 
fan cooling, chilled drinks and cool baths. Fever also increases metabolic demand by 
5% to 8% per degree (Marino, 2007). The replacement of daily fluid needs, 
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comprising of sensible, insensible and additional losses (vomiting, diarrhoea, fistula), 
is essential for the maintenance of adequate hydration. The sensible losses, primarily 
through sweat, are increased by 250ml per degree of fever. Insensible losses, from the 
lung and skin, increase by 50 to 75ml per degree of fever. 
 
2.5.6 Choose and Prescribe Antibiotic Therapy (Focus on Odontogenic 
Infections) 
 
Orofacial infections have far-reaching clinical implications due to its nature of 
rapidly progressive spreading and risk of mortality. Even though we live in an era of 
antibiotics, we know that this factor alone will not cure the infection (Hall et al., 
1968). 
 
The selection of the appropriate antibiotics is determined by pathogen, host factors, 
and pharmacological factors (reviewed in section 5.7. below). 
 
2.5.6.1 Pathogenic Factors 
 
This is determined by the type of organisms (refer to causes of infection) responsible 
for the infection and the organism’s resistance to antibiotics. Many authors 
(Fazakerley et al., 1993; Flynn et al. 1999; Miloro, 2004) have substantiated that mild 
odontogenic infections (outpatients) can be treated successfully with oral penicillin 
together with root canal therapy or extraction. However, it was found in studies 
comparing various antibiotics (clindamycin, amoxyllin, co–amoxiclav), that the 
recovery at 48 hours was better with the above antibiotic therapy. At seven days, the 
penicillin faired equally well (Fazakerley et al., 1993; Lewis et al., 1990; Gilmore et 
al., 1998). 
 
For odontogenic infections requiring hospital admission, more authors advocate the 
use of antibiotics other than penicillin. In the study by Flynn et al. (1999), he found a 
26% failure rate of Penicillin when used empirically in a series of 34 hospitalised 
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cases. Within this population, 31 patients were given penicillin (three had penicillin 
allergies). The authors reported that eight of the patients were reported to have 
‘therapeutic failure’. This was determined by swelling not subsiding, continued fever 
(> 48 hours) and continued raised white cell counts despite CT verified surgical 
drainage. 
 
In a second study by Flynn et al. (2006b), they found penicillin resistance in 19% of 
identified bacterial strains that occured 54% of the population. He found a 
‘therapeutic failure’ (same criteria as 1999 study) in 2%, and re-operation in 8% of 
cases. In a review article by Robertson and Smith (2009), they found that antibiotic 
resistance in the acute dental abscess has been increasing with the exception of 
metronidazole. Their findings showed resistance rates for amoxycillin ranging from 
9% to 54%. 
 
The specific bacterial species and their antibiotic resistance profiles will be analysed 
later in the discussion section. However, a brief description of the mechanisms of 
antibiotic resistance and the acquisition of these genes are briefly explained. 
Four mechanisms of bacterial resistance are known to occur: 
1. Inactivation of antimicrobial agent 
2. Active elimination of antibiotic 
3. Alteration of drugs target size 
4. Inability of drug to reach its target size 
 
These mechanisms can only occur if the bacteria have the genes to implement them. 
Four processes have been identified that enables these mechanisms to occur: 
1. Spontantaneous mutation 
2. Gene transfer (Bacterial conjugation with transfer of genetic material via 
plasmids) 
3. Bacteriophages (Viruses infecting bacteria  can insert genetic material) 
4. Mosaic Genes (Bacteria absorb fragments of dead members of related species, 
gaining genetic material) 
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2.5.6.2 Host Factors 
 
These factors need consideration in the management of each individual, as it may 
influence the choice of antimicrobial. These include allergy or intolerance to the 
antibiotic, immune compromise, previous antibiotic therapy, age and pregnancy. 
 
ii)  Allergy Intolerance 
 
Penicillin is the most frequently prescribed antibiotic for odontogenic infection. It is 
found that between 1 to 10% of patients who initially take penicillin, develop an 
allergic reaction. Those who do not have an adverse reaction, have a 1% chance of 
future allergy development upon re-exposure (Craig and Mende, 1999). In this study, 
it was also noted that 10 to 15% of penicillin–allergic patients exhibited cross–
sensitivity to cephalosporins. Severe reactions were reported to be rare (Craig and 
Mende, 1999). 
 
ii) Immune System Compromise 
 
Patients with immunosuppression are often unable to mount adequate response to 
invading pathogens. It is therefore recommended that bactericidal rather than 
bacteriostatic antibiotics be used. Bactericidal antibiotics arrest vital cell processes 
such as cell wall synthesis and nucleic acid synthesis (Table 4). 
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Table 4. Bactericidal and bacteriostatic antibiotics [Flynn and Halpern, 2003] 
______________________________________________________ 
Bactericidal    Bacteriostatic 
______________________________________________________ 
β-lactams    Macrolides 
 penicillins       erythromycin 
 cephalosporins      clarithromycin 
 carbapenems       azithromycin 
 monobactams   Clindamycin 
Aminoglycosides   Tetracyclines 
Vancomycin    Sulfa antibiotics 
Metronidazole 
Fluoroquinolones 
 
According to Flynn and Halpern (2003), HIV positive subjects responded as well as 
their HIV negative counterparts in their ability to resist oral bacterial infections until 
late in the course of the disease. They explained that this was due to the normal B–
lymphocyte function, which is mainly responsible for combating bacterial pathogens. 
These lymphocytes are normal until the end stays of the illness when all white cells 
are affected. They also stated that fungal and viral infections are prevalent due to the 
poor cell mediated immunity (T cell). In the study by Flynn et al. (2006a) they had 
one HIV case and two diabetic cases with sepsis. Although these cases were not 
severe, they required extensive care. 
 
iii) Previous Antibiotic Therapy 
 
The use of antibiotics is known to cause selection of resistant organisms. It was also 
found those individuals who were using antibiotics just prior to or at the time of 
infection, had a higher percentage of resistance to that antibiotic (Doern et al., 1996). 
 
iv) Age and Pregnancy 
 
Certain antibiotics should not be used in children. Tetracyclines should be avoided in 
children under the age of 10 due to permanent dental staining. Fluoroquinolones 
cause chondrotoxity (until puberty) and imipenem poses a seizure risk. 
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In pregnancy, it is recommended that risk benefit assessments be used if no other 
alternatives are found (Table 5). 
 
Table 5. Pregnancy risk categories of selected antibiotics [Flynn and Halpern, 2003] 
____________________________________________________________________ 
Antibiotic    Pregnancy risk category        Pregnancy risk 
____________________________________________________________________ 
 
Penicillins 
 penicillin G and V   B 
 ampicillin    B 
 amoxicillin    B 
 amoxicillin/clavulanate  B 
 ticarcillin/clavulanate   B 
Cephalosporins 
 cephalexin    B 
 cefazolin    B 
 cefaclor    B 
 cefuroxime    B 
 cefoxitin    B 
 cefotaxime    B 
Carbapenems 
 imipenem    C   Spontaneous abortions in  
                                                                    monkeys 
 meropenem    B 
Macrolides 
 erythromycin    B 
 clarithromycin    C   Fetal defects in mice and  
                                                                                            monkeys 
 azithromycin    B 
Antianaerobic 
 clindamycin    B 
 metronidazole    B 
Fluoroquinolones 
 ciprofloxacin    C   Spontaneous abortions in 
                                                                                            rabbits 
 moxifloxacin    C   Fetal toxicity in rodents and  
                                                                                            monkeys 
Aminoglycosides 
 gentamicin    D   Ototoxicity in human fetuses 
 tobramycin    D   Ototoxicity in human fetuses 
Other 
 vancomycin                                C                                    Potential ototoxicity in  
                                                                                            human fetuses 
 tetracyclines    D   Intrinsic dental staining 
 doxycycline    D   Intrinsic dental staining 
 linezolid                                     C                                     Fetal toxicity in rodents 
 telithromycin    B 
A - No risk (pregnancy studies)  
B - Animal studies no risk 
C - Animal studies toxicity 
D - Evidence of human risk 
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2.5.7 Administer the Antibiotic Properly 
 
2.5.7.1 Pharmacological Factors 
 
i) Pharmacodynamics 
 
It is essential that the antibiotic chosen is effective against all the likely pathogens. 
Included are two tables that reflect the spectrum of the most common antibiotics used 
in orofacial infections. Refer to Table 6. (Flynn and Halpern, 2003). 
 
The benefit of the correct antibiotics can only be realised if the antibiotic 
concentration is high enough to be effective in the area of infection (tissue 
distribution). Clindamycin is the antibiotic that reaches the highest concentration 
within an abscess, reaching 33% of serum levels (Karsten, 1999), thus rendering it 
very effective in odontogenic infections. Tetracyclines, clindamycin and 
fluoroquinolones achieve the best bone penetration. Numerous antibiotics cross the 
inflamed blood brain barrier (Table 7), but clindamycin, macrolides, aminoglycosides 
and most cephalosporin are amongst those antibiotics that are not appropriate for 
managing meningitis associated with orofacial sepsis. 
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TTable 6. Antibiotics of choice for head and neck pathogens [Flynn and Halpern, 2003] 
    
Pathogen    Type First choice antibiotics Alternative antibiotics 
Actinomyces   +, R, A  Penicillin G or ampicillin Doxycycline 
   Clindamycin 
   Erythromycin 
Bacteroides fragilis    _, R, AN Metronidazole Clindamycin 
   
Cefoxitin, not cefotetan 
(DOT) 
   Ampicillin/sulbactam 
Clostridium species +, R, AN Penicillin G F clindamycin  Metronidazole 
(except C. difficile)   Doxycycline 
   Cephalosporin (1st)a 
Clostridium difficile  +, R, AN Metronidazole p.o. Vancomycin p.o. 
   Bacitracin p.o. 
Eikenella corrodens  _, R, A  Penicillin G or V  Fluoroquinolones 
  Amoxicillin 
TMP/SMX (avoid 
clindamycin) 
  Amoxicillin/clavulanate Vancomycin 
Enterococcus faecalis +, C, F Ampicillin +/- gentamicin Ampicillin/sulbactam 
(group D streptococcus)  (for endocarditis or meningitis) Linezolid 
Enterococcus faecium (group D +, C, F F 
Linezolid + 
stin/dalfopristin +/- 
Teicoplanin + 
aminoglycoside 
streptococcus: b-lactamase +,  choramphenicol +/- doxycycline (van B) 
aminoglycoside and   
For some strains: no 
effective 
vancomycin resistant)   
regimen (I.D. 
consultation) 
Escherichia coli  _, R, A  Ticarcillin/clavulanate 
Meropenem for central 
nervous system 
  Cephalosporins Aztreonam 
  Imipenem TMP/SMX 
  Fluoroquinolones Tobramycin 
Fusobacterium species  _, R, AN  Penicillin G or V  Metronidazole 
   Clindamycin 
Haemophilus influenzae _, R, F  Amoxicillin/clavulanate 
Cefotaxime (if life 
threatening) 
(b-lactamase positive)  Cefaclor Ciprofloxacin 
  Azithro/clarithromycin TMP/SMX 
 _, R, A   Cephalosporin (3rd)* Tobramycin 
Klebsiella pneumoniae   Fluoroquinolones  Ticarcillin/clavulanate 
   Imipenem/cilastatin 
Klebsiella pneumoniae _, R, A  Imipenem/cilastatin Meropenem 
(producing extended spectrum  Fluoroquinolones  
b-lactamases: ESBLs)    
Pasteurella multocida _, R, A  Penicillin G Doxycline 
(eg, dog and cat bites)  Amoxicillin/Clavulanate Cephalosporin (2nd)a 
   TMP/SMX 
Peptostreptococcus +, C, AN Penicillin G or V Clindamycin 
(and former Peptococcus)   Doxycline 
   Vancomycin 
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Table 6. Antibiotics of choice for head and neck pathogens (continued) 
    
Pathogen    Type First choice antibiotics Alternative antibiotics 
 
Black pigmented oral _, R, AN  Clindamycin PCN + metronidazole 
Anaerobes (Prevotella and   Amoxicillin 
Porphyromonas)   Cefotetan 
Proteus vulgaris (indole +)    _, R, A Cephalosporin (3rd) Tobramycin 
  Fluoroquinolones  Imipenem 
   Ticarcillin/clavulanate 
Pseudomonas aeruginosa   _, R, A  Ciprofloxacin 
Aztreonam + 
ceftazidime 
  Tobramycin 
Piperacillin + 
tobramycin 
   Cefepime + tobramycin 
Salmonella typhi    _, R, A Fluoroquinolones Chloramphenicol 
  Ceftriaxone  Amoxicillin 
   TMP/SMX 
Serratia marcescens   _, R, A  Cephalosporin (3rd) Gentamicin 
  Imipenem  Aztreonam 
  Meropenem  
  Fluoroquinolones  
Shigella    _, R, A Fluoroquinolones TMP/SMX + ampicillin 
  Azithromycin  
Staphylococcus aureus +, C, A  Penicillinase-resistant Cephalosporin (1st)a 
(methicillin sensitive)  Penicillin Vancomycin 
   Clindamycin 
Staphylococcus aureus +, C, A  Vancomycin  Teicoplanin 
(methicillin resistant)   
Quinupristin-
dalfopristin 
   
TMP/SMX (some 
strains) 
   Linezolid 
Staphylococcus aureus +, C, A  No effective regimen Quinupristin/dalfopristin 
(methicillin and  Try vancomycin F rifampin Linezolid 
vanco mycin resistant)    
Staphylococcus epidermidis    
(methicillin resistant)    
 +, C, A  Vancomycin (+ rifampin Quinupristin/dalfopristin 
  + gentamicin  
  for prosthetic valve endocarditis)  
Staphylococcus epidermidis +, C, A  Quinupristin/dalfopristin Vancomycin (high dose) 
(methicillin and  Linezolid New fluoroquinolones?b 
glycopeptide resistant)   
(rapid resistance a 
problem) 
Streptococcus pneumoniae +, C, A  Penicillin G or V Cefuroxime, cefipime 
(Pneumococcus)  Ceftriaxone Imipenem 
(penicillin sensitive)  Amoxicillin New fluoroquinolonesb 
Streptococcus pneumoniae +, C, A  Vancomycin + Rifampin  Clindamycin 
(Pneumococcus) (multiantibiotic   
New fluoroquinolones 
(in vitro) 
resistant, including high-level    
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Table 6. Antibiotics of choice for head and neck pathogens (continued) 
    
Pathogen    Type      First choice antibiotics  Alternative antibiotics  
Penicillin, erythromycin,    
tetracycline, chloramphenicol,    
and TMP/SMX)    
Streptococcus pyogenes +, C, A  Penicillin G or V (+ gentamicin Cephalosporin (1st)a 
(b-hemolytic streptococcus)  if serious group B infection) Erythromycin 
Streptococcus viridans +, C, A Penicillin G or V Cephalosporin (1st)a 
(a-hemolytic streptococcus)   Macrolides 
Fungal organisms    
Blastomyces  Fungus  Amphotericin B Itraconazole (if surface) 
  (for systemic cases) Fluconazole (if surface) 
Candida    Fungus Fluconazole Nystatin (if surface) 
  Amphotericin B Clotrimazole (if surface) 
  (for systemic cases) 
Ketoconazole (if 
surface) 
   Itraconazole (if surface) 
Coccidioides immitis    Fungus Itraconazole Fluconazole 
   Amphotericin B 
Histoplasma  Fungus  Amphotericin B (for systemic 
Itraconazole 
(immunocompetent) 
  or immunocompromised cases) 
Itraconazole 
(immunocompromised) 
    
    
Mucormyces  Fungus  Amphotericin B 
 Control underlying 
systemic disease 
    
Abbreviations: A, aerobe; AN, anaerobe; C, coccus; DOT, distasonis, ovatus, and thetaiotamicron group of B. fragilis 
F, facultative; PCN, penicillin; R, rod; TMP-SMX, trimethoprim-sulfamethoxazole.  
Data from Gilbert DN, Moellering RC Jr, Sande MA. The Sanford guide to antimicrobial therapy 2002. 32nd edition. New 
Park (VT): Antimicrobial Therapy Inc.; 2002.   
+ = gram positive.    
_ = gram negative.    
a Number in parentheses after cephalosporins refers to generations within the cephalosporin family. 
b New fluoroquinoles are gati-, gemi-, lero-, moxi-, sparfloxacin.  
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Table 7. Selected antibiotics and the blood-brain barrier [Flynn and Halpern, 
2003] 
_________________________________________________ 
Cerebrospinal fluid     Antibiotic 
__________________________________________________________________ 
Therapeutic levels achieved   Penicillins 
      ampicillin 
      nafcillin 
      penicillin G, high dose 
      ticarcillina 
      piperacillina 
      Cephalosporins 
      ceftazidime 
      cefuroxime 
      ceftriaxone 
      Carbapenem 
      Meropenemb 
      Fluoroquinolones 
      levofloxacin 
      ciprofloxacinc 
      Other antibiotics 
      metronidazole 
      trimethoprim/ 
      sulfamethoxazoled 
      vancomycinee 
      Antifungal drugs 
      fluconazole 
      flucytosine 
      Antiviral drugs 
      acyclovir 
      foscarnet 
      ganciclovir 
      zidovudine 
Therapeutic levels not achieved   Cephalosporins 
      cefazolin 
      cephalexin 
      Aminoglycosides 
      Macrolides 
      erythromycin 
      clarithromycin 
      azithromycin 
      clindamycin 
      Antifungal drugs 
      amphotericin 
      itraconazole 
      Antiviral drugs  
      saquinavir 
      zidovudine 
 
       
Data from Gilbert DN, Moellering RC Jr, Sande MA. The Sanford guide to antimicrobial therapy. 32nd edition. Hyde Park 
(VT): Antimicrobial Therapy, Inc.; 2002. 
a Levels effective for P. aeruginosa and coliforms may not be reached. 
b Imipenem is avoided in meningitis because of seizure potential. Meropenem is preferred. 
c Does not reach adequate cerebrospinal fluid levels for streptococci. 
d Not adequately effective against Neisseria species and coliforms. 
e High doses are needed for resistant streptococci. 
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ii) Pharmacokinetics 
 
This is the reflection of the potency of an antibiotic and is determined by the 
minimum inhibitory concentration (MIC). It is usually expressed as MIC50 and 
MIC90. This is the minimum concentration of an antibiotic required to kill 50% 
(MIC50) or 90% (MIC90) of the pathogens. 
 
In time–dependant antibiotics (β – lactam group and vancomycin), it is essential that 
the serum concentration is above the MIC for at least 40% of the dosage interval. In 
concentration–dependant antibiotics (fluoroquinolones and aminoglycosides), the 
efficacy is dependant on the serum concentration ratio of that antibiotic to kill 50% 
(MIC50) or 90% (MIC90) of pathogens. 
 
The dosage interval of time–dependant antibiotics is determined by the half-life (t1/2) 
of the drug. For explanatory purposes: the half life of benzyl penicillin (Pen G) is 30 
minutes, implying that for every half an hour, 50% of the drug is eliminated from the 
serum. In 2.5 hours (5 X t1/2), only about 3% of the drug remains. Thus, if 2 MU Pen 
G was administered, the serum concentration after 3 hours (6 X t1/2), would be 
approximately 0.3μg/ml and since the MIC90 of S.viridans is 0. 2μg/ml this would 
mean that 2 MU of Pen G will remain above MIC90 for about 75% of the time. 
 
2.5.7.2 Empiric Antibiotics 
 
These are the antibiotics given prior to the availability of culture and sensitivity tests, 
taking into account the most likely pathogens involved and their antibiotic resistance 
profiles as well as host factors, pharmacodynamics, pharmacokinetics and cost 
implications for the patient. 
 
Table 8 by Flynn and Halpern (2003) complies with the analysis of the above 
literature. 
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Table 8. Empiric antibiotics of choice for head and neck infections  
[Flynn and Halpern, 2003] 
 
Type of infection      Empiric antibiotic of choice 
__________________________________________________________________________________ 
Odontogenic infections 
Outpatient       Penicillin 
       Clindamycin 
       Cephalexin (or other first-generation 
       cephalosporin) 
    Penicillin allergy   Clindamycin 
       Cephalexin (only if nonanaphylactoid 
       penicillin reaction) 
Inpatient      Clindamycin 
       Ampicillin + metronidazole 
       Ampicillin + sulbactam 
    Penicillin allergy   Clindamycin 
       Moxifloxacin 
       Cefotaxime (only if nonanaphylactoid 
       penicillin reaction) 
Rhinosinusitis 
Acute        Amoxicillin 
       Amoxicillin/clavulanate 
       Cefuroxime 
       Moxifloxacin (over 18 years of age) 
    Penicillin allergy  Clarithromycin or azithromycin 
       Telithromycin 
       Moxifloxacin (over 18 years of age) 
Chronic        Antibiotics not effective: 
       otolaryngologic consultation 
Intubated      Imipenem or meropenem 
       Ticarcillin or piperacillin 
       Ceftazidime + vancomycin 
       Cefepime 
Fungal Osteomyelitis     Amphotericin B 
of the jaw      Clindamycin 
       Ampicillin + metronidazole 
       Ampicillin + sulbactam 
    Penicillin allergy  Clindamycin 
       Moxifloxacin 
Histoplasmosis                                 Itraconazole 
and blastomycosis 
       Fluconazole   
       Amphotericin B 
       (systemic or disseminated) 
Candidiasis 
Oral, non-AIDS       Fluconazole or itraconazole 
       Nystatin or clotrimazole 
Oral, AIDS      Fluconazole or itraconazole 
       Amphotericin B 
 
Data from Gilbert DN, Moellering RC Jr, Sande MA. The Sanford guide to antimicrobial therapy. 32nd edition. Hyde Park 
(VT): 
Antimicrobial Therapy Inc.;2002. 
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2.5.8 Evaluate the patient frequently 
 
With empiric antibiotics and adequate surgical treatment, as well as all medical 
supportive care provided (emotional and psychological, counseling if required), 
improvement of treatment should be seen in 48 hours (Marino, 2007). The 
physiological recovery of the patient can be measured by the improvement of 
symptoms (pain, swelling), inflammatory markers, procalcitonin (CRP has slower 
response) and an improvement in observations (temperature, heart rate, tachypnoea, 
urine output) (Marino, 2007). 
 
Failure of improvement in the patient can be attributed to the following: 
 
1. Inadequate surgery 
2. Depressed host defenses 
3. Presence of foreign body 
4. Antibiotic problems - incorrect bacterial diagnosis 
- dose of antibiotic too low 
- drug not reaching site 
- antibiotic not administered 
 
With failure to improve at 48 hours, the patient will require a further complete 
physical examination. Care should be taken not to overlook other medical conditions 
like tuberculosis, malaria and bacteremia with early septic shock (established shock 
SIRS criteria). The Gram stain would have to be reviewed and antibiotic therapy 
changed accordingly. The patient should also be rescanned for the following:  
inadequately drained collection, new fascial space collection, distant spread 
(mediastinitis, cavernous sinus thrombosis and meningitis) and even for foreign 
bodies. Blood tests should be redone to assess pathophysiology.   
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CHAPTER 3 
 
MATERIALS AND METHODS 
 
3.1 Introduction 
 
A prospective study was undertaken over a period of four consecutive months in 
patients with orofacial sepsis who required admission or incision and drainage. 
Patients were referred to either of the two Maxillo-Facial and Oral Surgery Units in 
the Western Cape, namely Groote Schuur Hospital or the University of the Western 
Cape Oral Health Centre (Dental Faculty, part of Tygerberg Academic Hospital 
complex). The study included written informed consent for treatment and HIV testing 
from either the patient or his/her legal guardian.  
 
3.2 The Study Sample 
 
The initial study sample consisted of fifty-one patients with orofacial sepsis that 
required admission or incision and drainage. These patients were referred to the two 
Maxillo-Facial and Oral Surgery Units in the Western Cape. Six patients were 
excluded from the sample, as they did not meet the inclusion criteria of the study. Of 
these, two patients refused to have HIV testing and three were excluded due to the 
omission of essential laboratory results (MCS or HIV results). The last exclusion was 
due to an analysis error where the pus swab was incorrectly sent to the cytology 
laboratory. This left a population sample size of forty-five cases. 
 
3.3 Inclusion Criteria 
 
1. Any patient with orofacial sepsis requiring admission with incision and 
drainage was considered. 
2. Criteria for the admission to hospital included: any cause of orofacial swelling 
affecting one or more fascial spaces of the head and neck; impending threat to 
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vital structures including the airway; fever greater than 38.5ºC; patient 
requiring general anaesthesia; and patient requiring supportive medical 
therapy. 
3. Written, informed consent for treatment and HIV testing was obtained from 
either the patient or his/her legal guardian (the latter applicable to cases of a 
minor, patients who were legally unable to give consent due to mental 
handicap, altered mental state due to illness or substances altering cognitive 
function). The consent process and procedures were explained to the patient in 
his/her language of choice. 
4. Patients who had microbial analysis of the causative pathogen. 
 
3.4 Exclusion Criteria 
 
1. Patients who refused to participate in the study. 
2. Failure to meet any of the inclusion criteria of this study. 
 
3.5 Treatment Methods 
 
A standardised treatment protocol was used for all patients in this study. A thorough 
initial consultation was conducted, comprising of history, physical examination, HIV 
pre-test counseling and blood tests (HIV testing, full blood count, plasma ureum and 
electrolytes testing). Panoramic dental radiographs were taken, and if not available, 
left and right oblique views were used. CT scans (with contrast) were considered on 
admission in the case of airway difficulties or in severe cases where no pus was 
drained. Patients were treated under local anaesthesia unless there was airway 
compromise. In the case of children or adults where problems of patient cooperation 
was anticipated, general anaesthesia was also used.  
 
The patient’s skin was prepared with antiseptic swabs prior to any skin incisions. This 
was followed by incision and drainage of all fascial spaces, via mucosal or ‘through-
and-through’ skin to mucosal incisions in  the majority of cases. Pus swabs were 
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taken from within the opened fascial space, avoiding possible contamination with 
skin, mucosa or saliva. Radio-opaque corrugated drains were placed in all fascial 
spaces and secured with sutures to either the mucosa or the skin. These wounds were 
covered with dry dressings. 
 
 
Adult patients (no allergy history), received a test dose of 50 000 units, fifteen to 
twenty minutes prior to the loading dose of 5 million units of intravenous Benzyl 
penicillin. Thereafter, a six hourly dose of 2 million units of Benzyl Penicillin 
together with an eight hourly dose of 500mg of intravenous Metronidazole was 
administered. Patients, who were pregnant and not penicillin-allergic, received the 
same regimen except that Metronidazole was omitted in the first trimester. Children 
not allergic to penicillin, received an intravenous test dose of 25 000 units of Benzyl 
penicillin, fifteen to twenty minutes prior the loading dose of 150 000 units/kg/day in 
four divided doses, and Metronidazole 7.5mg/kg/8-hourly. Clindamycin was 
administered in the case of penicillin-allergic patients. In the case of adult patients, 
600mg of intravenous Clindamycin was given at six hourly intervals. Children 
received a dose of 25mg/kg/day in four divided doses.  
 
Blood and pus swabs were sent to the laboratory for appropriate analysis within thirty 
to forty minutes from being obtained. Tests for full blood count, ureum and 
electrolytes, HIV and pus swab analysis were sent to the haematology, chemistry, 
virology and microbiology laboratories respectively. 
 
If, after 48 hours, there was no clinical improvement (temperature, pain, swelling), 
the gram stains were then critically assessed. The patient would then be thoroughly 
re-examined and clinically reassessed as to the spread of infection and efficacy of the 
drainage of previously treated fascial spaces. Other causes would also be considered 
namely, presence of foreign bodies or other medical illnesses. It was at this point, 
depending on the severity of the infection or a possible threat to airway, that further 
blood investigations and/or special investigations e.g. CT scans, would be considered. 
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Based on these findings, antibiotics could be adjusted, re-drainage of fascial spaces 
could be considered and interdisciplinary assistance could be sought. A minimum of 
twice-daily irrigation of drains was mandatory until no pus extrusion from the wound 
occurred. The drains were serially removed from each of the fascial spaces once pus–
free irrigation was achieved. The patient were discharged on oral antibiotics and 
referred to local day hospitals (closest to the patient’s residences) for regular 
dressings. The patients would return to the unit for follow-up treatment in 
approximately four to seven days. 
 
3.6 Data Collection 
 
An information capture sheet, collecting all relevant data was formulated (Appendix 
1) and recorded in duplicate. The original capture sheet served as the patient’s notes 
and the copy was retained for selective recording on a statistics capture form 
(Appendix 2). The demographic details of the patient included age, gender, previous 
medical history (including pre-admission HIV status), medical illness (including 
diabetes and autoimmune disease), medication, allergies, previous surgical history 
and social habits (including smoking, alcohol abuse and drug abuse). 
 
The location of the abscess was recorded according to the fascial spaces involved. 
Any other probable location was also recorded. Possible causes of infection were 
noted and other forms of infection including necrotising fasciitis and osteomyelitis 
were recorded. HIV test results and CD4 counts (where known) were recorded. The 
microbiological test results were entered according to the type of organisms seen with 
Gram Stain, as well as the type of flora cultured (‘normal flora’ or ‘mixed growth’). 
If ‘no growth’ was obtained, it was specified whether antibiotics were administered 
pre-consultation or not.  
 
Blood test results including full blood counts and urea and electrolytes, were 
recorded. If the patient exhibited poor clinical improvement, changes in antibiotics 
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and re-debridement or re-drainage, were considered. In the case of patients who were 
admitted to hospital, the length of stay was recorded as the number of days admitted. 
 
3.7 Processing of Specimens (Microbiology) 
 
Samples were received at the microbiology laboratory via the hospital’s ‘tube 
system’. Upon receipt of these samples, they were processed immediately after 
logging and labeling thereof. Gram stain, cultivation and identification of 
microorganisms were conducted using the Department of Health Standard Guidelines 
of Microbiological Techniques. 
 
The sensitivity of the microorganisms cultured or the selected media (based on the 
type of infection) were assessed, using the Kirby Baurer Diffusion Method (Appendix 
3). The microbiology culture was identified, tabulated and analysed according to the 
sensitivity tests that were conducted. 
 
3.7.1 Antibiotics used in Sensitivity Testing 
 
1. Penicillin 
2. Clindamycin 
3. Cloxacillin 
4. Vancomycin 
5. Gentamycin 
6. Cotrimoxazole 
7. Ciprofloxacin 
8. Cefuroxime 
9. Erythromycin 
10. Cefotaxime 
11. Coamoxiclav 
12. Tetracycline 
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Sensitivity tests for aerobe and facultative species were carried out according to the 
type of organism cultured (expected resistance profiles) and standard guidelines of 
laboratory practice (CSLI Guideline). The above-mentioned antibiotics were tested 
using either the antibiotic disc method or an automated E-Test Strip Test. With the E-
Test strip method, MIC values were generated for each bacterial sample. Intermediate 
resistance in each of these tests (antibiotic disc method or the E-Test Strip) was 
specific for each organism and each bacteria and was assessed using the CSLI 
Guideline. (Antibiotic resistance testing on anaerobic organisms cultures are not done 
at either Groote Schuur or Tygerberg hospitals). 
 
3.8  HIV Testing 
 
In this study, HIV results were based on two consecutive tests. The first test (Vidas 
HIV DVO ©) is highly sensitive in order to prevent non-reactive samples testing 
negative. The second (AxSYM HIV Ag/Ab Combo ©) is more specific  in order to 
prevent false positives. The patients were diagnosed as HIV positive when both of 
these tests yielded positive results. In the case of the second test being indeterminate, 
both tests were repeated within two to four weeks from the initial analysis. 
 
The tests used at the laboratories of Groote Schuur and Tygerberg Hospitals were the 
Vidas HIV DVO © and the AxSYM HIV Ag/Ab Combo © tests. The Vidas HIV 
DVO © showed a sensitivity of 100% and predicative positive values of 90.4%. 
(Fierz, Erb, 2003). The AxSYM HIV Ag/Ab Combo © test had a specificity of 
99.87% and 100% sensitivity. 
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CHAPTER 4 
 
RESULTS 
 
Of the fifty-one consecutive patients with orofacial sepsis referred to the Maxillo-
Facial and Oral Surgery Units in the Western Cape, six subjects did not fulfill the 
inclusion criteria (refer to study sample), making this study population a total of 
forty-five (45) subjects. 
 
Table 9: Gender and HIV Prevalence 
 
Gender HIV Positive HIV Negative Percentage 
F 3 16 42.22% 
M 8 18 57.78% 
Total 11 34  
Percentage 24.44% 75.56%  
 
Table 9 is an analysis of the study population according to gender and HIV status 
(confirmed via blood tests). Analysis of the population showed a fair male 
predominance (15.56%), with almost a quarter of the population being HIV positive. 
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Table 10: Age Analysis 
 
Sex Data HIV Positive HIV Negative Total 
F Count of Study No: 3 16 19 
  Count of Age 3 16 19 
  Average of Age 27.00 34.25 33.11 
  StdDev of Age 5.57 20.31 18.83 
  Min of Age 21 2 2 
  Max of Age 32 76 76 
M Count of Study No: 8 18 26 
  Count of Age 8 18 26 
  Average of Age 24.88 31.50 29.46 
  StdDev of Age 9.03 9.88 9.94 
  Min of Age 11 19 11 
  Max of Age 39 52 52 
Total Count of Study No: 11 34 45 
Total Count of Age 11 34 45 
Total Average of Age 25.45 32.79 31.00 
Total StdDev of Age 8.02 15.48 14.30 
Total Min of Age 11 2 2 
Total Max of Age 39 76 76 
 
Table 10 is an analysis of age, indicating average age with the standard deviation, 
minimum and maximum ages in relation to gender and HIV status. The average age 
of the HIV positive group was approximately 7 years younger. The HIV negative 
group had two subjects with extremes in age variation (youngest subject: 2 years and 
the oldest being 76 years). Even if these two variables were removed, the average age 
difference between the two groups remained more than 5 years. 
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On the first consultation, the patient’s history was recorded, each subject was 
specifically asked about his/her HIV status, autoimmune diseases and allergies. Our 
findings were that no subjects had any known allergies, two had diabetes and five 
were aware of their HIV positive status. Of the five HIV positive patients, only one 
was on anti-retroviral treatment. HIV testing revealed that 55% (six subjects) were 
unaware of their HIV positive status. Only three patients were aware of their CD4 
counts (verified by the study, as the NHLS system is linked to day hospitals). Table 
11 reflects the three subjects’ CD4 counts according to gender. 
 
Table 11: CD4 T-lymphocyte Counts 
 
Sex Data 
HIV 
Positive 
HIV 
Negative Total 
F Count of Study No: 3 16 19 
  Count of CD4 count 2 0 2 
  Average of CD4 count 308.00  308.00 
  StdDev of CD4 count 400.22  400.22 
  Min of CD4 count 25  25 
  Max of CD4 count 591  591 
M Count of Study No: 8 18 26 
  Count of CD4 count 1 0 1 
  Average of CD4 count 172.00  172.00 
  StdDev of CD4 count    
  Min of CD4 count 172  172 
  Max of CD4 count 172  172 
Total Count of Study No: 11 34 45 
Total Count of CD4 count 3  3 
Total Average of CD4 count 262.67  262.67 
Total StdDev of CD4 count 293.69  293.69 
Total Min of CD4 count 25  25 
Total Max of CD4 count 591  591 
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Table 12: Causes of Sepsis 
 
Causes of Infection HIV Positive HIV Negative Total Percentage 
Teeth 7 25 32 71.11% 
Skin  0 1 (Poly trauma) 1 2.22% 
Septic fracture 3 4 7 15.56% 
Uknown 1 2 3 6.67% 
Lose screw post-orif 0 1 1 2.22% 
Wire ORIF - became 
septic 0 1 1 2.22% 
Total 11 34 45 100.00% 
 
Table 12 indicates the possible causes of infections diagnosed via clinical history or 
radiographic examinations. The most common cause was related to teeth with 
63.64% and 73.53% in the HIV positive and negative groups respectively. All except 
two were due to decayed teeth. One was due to pericoronitis and the other was a 
periodontal abscess. This was followed by septic jaw fractures as the second most 
common cause with 27.27% and 12% for the HIV positive and negative groups 
respectively. There were two subjects where the cause could not be identified. One 
interesting case was an 11-year-old boy who was referred for a facial abscess and 
only after a thorough history and examination, it was found that he had a septic glans 
penis following ritual circumcision. 
  
The most common teeth implicated were the mandibular posterior teeth (excluding 
3rd molars) with 42.86% and 44.0% in the HIV positive and negative groups 
respectively. Second most common were the mandibular 3rd molars (Table 13). 
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Table 13: Most Common Causative Teeth  
 
Teeth (specify) 
HIV  
Positive 
HIV 
negative Total Percentage
Maxillary ant teeth 0 2 2 6.25% 
Maxillary bicuspids 
and 1st & 2nd molars 2 2 4 12.50% 
Maxillary 3rd molars 0 0 0 0% 
     
Mandibular ant teeth 0 0 0 0% 
Mandibular bicuspids 
and 1st & 2nd molars  3 11 14 43.75% 
Mandibular 3rd molars  2 9 11 34.38% 
     
Multiple maxillary 
primary teeth 0 1 1 3.13% 
 
Intravenous Penicillin G and metronidazole were administered to all except one 
subject, as no antibiotic allergies were suspected or reported. This subject was 
pregnant (first trimester) and had 3 fascial spaces involved (right buccal, right 
submandibular and right lingual spaces). In this case, metronidazole was omitted. In 
subjects where infections were caused by unknown etiology (three subjects), where 
skin organisms (one subject) were involved, or with severe infections like Ludwig’s 
Angina (six subjects), intravenous cloxacillin was added. 
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Table 14: Fascial Spaces Frequency According to Location 
 
Fascial space HIV positive HIV negative Total Percentage 
Buccal  2 (18%) 14 ( 41%) 16 23.88% 
Canine 3 (27%) 6 ( 18%) 9 13.43% 
Sublingual  0 6 ( 18%) 6 8.96% 
Submandibular  4 (36%) 11 ( 33%) 15 22.39% 
Submental 1(9%) 1 ( 3%) 2 2.99% 
Superficial Temporal  0 1 ( 3%) 1 1.49% 
Submasseteric 3 (27%) 6 ( 18%) 9 13.43% 
Retropharyngeal  0 1 ( 3%) 1 1.49% 
Periodontal abscess 0 1 ( 3%) 1 1.49% 
Post-auricular 0 1 ( 3%) 1 1.49% 
Ludwigs angina 1(9%) 5 (15%) 6 8.96% 
 
Table 14 indicates the types and number of fascial spaces involved. This table shows 
the frequencies of the fascial spaces in the HIV positive and negative groups. The 
percentages indicate the frequency of spaces infected per subject. The percentages in 
the HIV positive and negative columns added up to greater than 100%, as there was 
more than one fascial space infected per subject in certain cases (Table 15). 
 
Table 15: Number of Fascial Spaces per Subject 
 
Number of spaces HIV positive HIV negative 
1 9 (82%) 22 (65%) 
2 1 (9%) 6 (18%) 
3 0 1 (3%) 
4 0 3 (9%) 
5 1(9%) 1(3%) 
6 0 1(3%) 
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Table 15 indicates that only 18% of HIV positive subjects had more than one fascial 
space involved, and only 9% (one subject) had greater than two spaces infected. This 
compared well to the HIV negative group where 35% had more than one fascial space 
involved, and 18% (six subjects) had more than two spaces infected. All the subjects 
with more than four fascial spaces involved, were diagnosed with Ludwig’s Angina 
(bilateral submandibular, sublingual and submental spaces). Of these five cases 
(Ludwig’s Angina), only one was HIV positive. 
 
In the two cases requiring tracheostomies due to airway compromise, both subjects 
were HIV negative with no known immune-compromising factors and neither of 
these subjects had resistant bacteria. 
 
Table 16: Culture Result  
 
Culture HIV Positive HIV Negative Total Percentage 
Mixed growth 1 (9.90%) 3 (8.82%) 4 8.89% 
Normal flora 2 (18.18%) 5 (14.71%) 7 15.56% 
No growth 0 9 (26.47%) 9 20.00% 
 
Table 16: Mixed growth culture occurs when numerous species overgrow each other 
on the culture medium, making it difficult to identify the species. Normal flora are 
commensal bacteria and are considered to be a contaminant on the pus swab. No 
growth occurred in 26.47% of cases (9 subjects)  and presented in the HIV negative 
group only. A  CHI-Squared = 3.8814 and with P-Value = 0.0488 proving that 
with a > 95% confidence, ‘no growth’ is likely to occur in the HIV negative 
group. 
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Table 17: Antibiotics Administered in Cases with No Growth on Culture 
 
Types antibiotics HIV Positive HIV Negative 
Amoxycillin & Metronidazole 2 
Ampicillin & Metronidazole 4 
PenG, & Metronidazole  2 
Co-amoxiclav & Metronidazole 1 
 
Table 17 is the list of antibiotics administered by the referring clinic or private 
practitioners prior to the initial consultation at the Maxillo-Facial and Oral Surgery 
units. From this, it can be deduced that the sterile abscesses drained were penicillin-
sensitive in eight out of the possible nine cases. However, due to the extended 
spectrum of the combination of co-amoxiclav and metronidazole, we could not make 
any conclusions on the bacteria sensitivity to the first line antibiotic (penicillin). 
 
Table 18: Gram Stain Results 
 
Gram Stain HIV Positive HIV Negative 
Gram positive cocci 10 (90.91%) 27 (79.41%) 
Gram positive bacilli 6 (54.54%) 22 (64.70%) 
Gram negative Cocci 3 (27.27%) 4 (11.76%) 
Gram negative bacilli 7(63.64%) 18 (52.94%) 
 
Table 18: Gram positive cocci were the most common bacterial form found in both 
the HIV positive and negative groups. The second most common group was the Gram 
negative bacilli for the HIV positive group and the Gram positive bacilli for the HIV 
negative group with 63.64% and 64.70. These analyses were all reflected in six 
groups from 0 to 5. With 0 – no bacteria seen; 1 very scanty; 2 - scanty; 3 - moderate; 
4 - abundant; 5 – innumerable as reported from laboratory (Table 19). 
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Table 19: Gram Positive Bacilli 
 
Gram Positive Bacilli HIV Positive HIV Negative Total
1 & 2 5 8 13 
3 & 4 1 14 15 
Total 6 (54.54%) 22 (64.70%) 28 
  
Table 19 depicts the Gram Positive Bacilli analysed according to HIV status, with a 
statistically significant larger frequency of Gram Positive Bacilli in the HIV 
negative group as proven with CHI-Squared = 4.1815 and a P-Value = 0.0409. 
 
Figure 12. Gram Stain for HIV Positive Group 
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Figure 13: Gram Stain for HIV Negative Group 
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Table 20: HIV Positive Group Depicting Abnormalities in Blood Tests versus the 
Number of Fascial Spaces Involved  
 
No. of 
spaces  
Haemoglobin Platelets Sodium Potassium Chloride Urea Creatinine
1        
2 11.2 375 135 4.8 95 2.6 65 
1        
1   138 4.1 99 2 83 
5 15.8 33 140 4  5.2 72 
1 15.5 205 128 5 105 3.2 62 
1 13.5 329 141 3.2 100 4.2 85 
1        
1 9 148 141 4.8 110 3 63 
1 12 412 133  104 4.1  
1 14.3 215 137 3.7 101 3  
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Table 20: Abnormalities in blood tests did not seem to correlate with the extent 
(number of fascial spaces) of the abscesses. However, the HIV positive group (eight 
subjects with results) showed an alarmingly high number (seven subjects) of 
abnormalities in blood and electrolyte values.  
 
Analysis of the data comparing electrolyte values in the HIV positive and negative 
groups, indicated that all the electrolytes (sodium, potassium, chloride, urea and 
creatinine) did not have any statistical significant differences. However, in the HIV 
positive group there were many values slightly outside the normal range (according to 
NHLS laboratory values). Due to the small population size, this was not statistically 
significant. 
 
The full blood counts showed that the HIV positive females compared to the HIV 
negative female group had an average white cell count of 7.31 and 13.05 respectively. 
However, in the male HIV positive versus negative groups, the converse was found, 
with 21.00 and 14.02 respectively. This paradox could possibly be explained due to 
the small group of HIV positive females (three subjects) who had advanced stages of 
HIV. Only one of these subjects was on anti-retroviral medication, despite the low 
CD4 cell counts of two of the three patients. No CD4 count was available for the last 
patient. The male HIV positive group consisted of eight subjects; only two subjects 
were aware of their HIV status and one had a recorded CD4 count of 172. The small 
size of the female group with more advanced disease, could possibly explain the poor 
white cell response to the abscesses (Table 21). 
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Table 21: White Cell Count Comparing HIV Status and Gender 
 
Sex Data HIV Positive HIV Negative Total 
F Count of Study No: 3 16 19 
  Count of White cell count 3 8 11 
  Average of White cell count 7.31 13.05 11.49 
  StdDev of White cell count 2.87 2.16 3.48 
  Min of White cell count 4.17 10.4 4.17 
  Max of White cell count 9.8 16.9 16.9 
M Count of Study No: 8 18 26 
  Count of White cell count 4 9 13 
  Average of White cell count 21.00 14.02 16.17 
  StdDev of White cell count 8.52 6.14 7.38 
  Min of White cell count 11.2 4.52 4.52 
  Max of White cell count 29.4 22.8 29.4 
Total Count of Study no: 11 34 45 
Total Count of White cell count 7 17 24 
Total Average of White cell count 15.13 13.57 14.02 
Total StdDev of White cell count 9.62 4.60 6.27 
Total Min of White cell count 4.17 4.52 4.17 
Total Max of White cell count 29.4 22.8 29.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 63
Table 22: Haemoglobin Value in HIV Positive and Negative Groups According 
to Gender 
 
Sex Data HIV Positive HIV Negative Total 
F Count of Study No: 3 16 19 
  Count of Haemoglobin 3 8 11 
  Average of Haemoglobin 12.17 13.03 12.79 
  StdDev of Haemoglobin 3.25 2.13 2.34 
  Min of Haemoglobin 9 10.8 9 
  Max of Haemoglobin 15.5 17.2 17.2 
M Count of Study No: 8 18 26 
  Count of Haemoglobin 4 9 13 
  Average of Haemoglobin 13.70 14.41 14.19 
  StdDev of Haemoglobin 1.92 1.09 1.35 
  Min of Haemoglobin 11.2 12.4 11.2 
  Max of Haemoglobin 15.8 16 16 
Total Count of Study No: 11 34 45 
Total Count of Haemoglobin 7 17 24 
Total Average of Haemoglobin 13.04 13.76 13.55 
Total StdDev of Haemoglobin 2.46 1.76 1.96 
Total Min of Haemoglobin 9 10.8 9 
Total Max of Haemoglobin 15.8 17.2 17.2 
 
Table 22 reflects the haemoglobin value in HIV positive and negative groups. There 
was a lower haemoglobin value in the HIV positive group (both male and female) 
compared to the HIV negative group. However, it was not statistically significant. 
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Table 23: Platelet Counts in HIV Positive and Negative Groups According to 
Gender 
 
Sex Data HIV Positive HIV Negative Total 
F Count of Study No: 3 16 19 
  Count of Platelets 3 8 11 
  Average of Platelets 255.00 428.25 381.00
  StdDev of Platelets 138.92 157.19 166.45
  Min of Platelets 148 266 148 
  Max of Platelets 412 732 732 
M Count of Study No: 8 18 26 
  Count of Platelets 4 8 12 
  Average of Platelets 238.00 287.00 270.67
  StdDev of Platelets 152.32 59.02 95.53 
  Min of Platelets 33 198 33 
  Max of Platelets 375 405 405 
Total Count of Study No: 11 34 45 
Total Count of Platelets 7 16 23 
Total Average of Platelets 245.29 357.63 323.43
Total StdDev of Platelets 134.60 135.93 142.59
Total Min of Platelets 33 198 33 
Total Max of Platelets 412 732 732 
 
Table 23: Platelet counts in the HIV positive groups (both genders) were markedly 
lower than the negative groups. The average counts for the HIV positive group was 
245.29 and for HIV negative group, 357.63, with a difference of 112.34. Population 
distribution of platelets was illustrated using Side-by-Side Box and Whisker Plot. 
Statistical analysis, using Chi-Square and Kruskal-Wallis tests both confirmed a 
trend. This result was meaningful, but due to the small population size, was not 
statistically significant (0.160477). 
 
 
 
 
 
 65
Analysis of Variance Report 
Response Platelets 
 
Tests of Assumptions Section 
 Test Prob Decision 
Assumption Value Level (0.05) 
Skewness Normality of Residuals 2.1621 0.030614 Reject 
Kurtosis Normality of Residuals 1.5021 0.133059 Accept 
Omnibus Normality of Residuals 6.9309 0.031259 Reject 
Modified-Levene Equal-Variance Test 0.0540 0.818522 Accept 
 
Figure 14: Side-by-Side box and Whisker plot illustrating platelet counts according to 
HIV status 
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Side-by-Side box and Whisker plot  X : HIV positive    No: HIV negative 
 
Expected Mean Squares Section 
Source  Term Denominator Expected 
Term DF Fixed? Term Mean Square 
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A: HIV positive 1 Yes S(A) S+sA 
S(A) 21 No  S(A) 
Note: Expected Mean Squares are for the balanced cell-frequency case. 
 
Analysis of Variance Table 
Source  Sum of Mean  Prob
 Power 
Term DF Squares Square F-Ratio Level
 (Alpha=0.05) 
A: HIV positive 1 61454.47 61454.47 3.34 0.081660
 0.415082 
S(A) 21 385847.2 18373.68 
Total (Adjusted) 22 447301.7 
Total 23 
* Term significant at alpha = 0.05 
Response Platelets 
 
Kruskal-Wallis One-Way ANOVA on Ranks 
Hypotheses 
Ho: All medians are equal. 
Ha: At least two medians are different. 
Test Results 
  Chi-Square Prob 
Method DF (H) Level
 Decision(0.05) 
Not Corrected for Ties 1 1.96875 0.160581 Accept Ho 
Corrected for Ties 1 1.969723 0.160477 Accept Ho 
Number Sets of Ties 1 
Multiplicity Factor 6 
Group Detail 
  Sum of Mean 
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Group Count Ranks Rank Z-Value Median 
HIV negative  16 213.00 13.31 1.4031 308 
X (HIV positive)  7 63.00 9.00 -1.4031 215 
 
 
Table 24: Length of Stay in Hospital According to HIV Status and Gender 
 
Sex Data 
HIV  
Positive 
HIV 
Negative Total 
F Count of Study No: 3 16 19 
  Count of Length of stay in hospital 3 16 19 
  Average of Length of stay in hospital 3.00 4.38 4.16 
  StdDev of Length of stay in hospital 1.00 2.99 2.79 
  Min of Length of stay in hospital 2 0 0 
  Max of Length of stay in hospital 4 10 10 
M Count of Study No: 8 18 26 
  Count of Length of stay in hospital 8 18 26 
  Average of Length of stay in hospital 5.00 3.00 3.62 
  StdDev of Length of stay in hospital 2.39 1.53 2.02 
  Min of Length of stay in hospital 2 0 0 
  Max of Length of stay in hospital 8 6 8 
Total Count of Study No: 11 34 45 
Total Count of Length of stay in hospital 11 34 45 
Total Average of Length of stay in hospital 4.45 3.65 3.84 
Total StdDev of Length of stay in hospital 2.25 2.40 2.36 
Total Min of Length of stay in hospital 2 0 0 
Total Max of Length of stay in hospital 8 10 10 
 
Table 24: The average length of admission in hospital was 3.84 days. One was 
admitted for 10 days and three were not admitted. These three subjects were all 
healthy individuals between 36 and 39 years old, and did not fulfill the admission 
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criteria. Two of these subjects had canine space abscesses and one had a buccal space 
abscess. Table 24 shows that the HIV positive group’s average stay was longer than 
HIV negative group by almost one day (0.8 of day). Even with a small population, a 
trend could be seen. The length of stay was further analysed, depicting the number 
of days admitted using a stem and leaves distribution table (Table 25). 
 
Table 25: Length of Stay in Hospital – Stem and Leaves Table  
 
Number of days 
HIV positive Stem Leaves 
Number of days 
HIV Negative Stem Leaves 
0  0 000 
1  1  
2 22 2 22222 22 
3 333 3 33333 33333 33 
4 44 4 44 
5 5 5 55 
6  6 66 
7 7 7 77 
8 88 8 8 
9  9 9 
10  10 0 
11  11  
 
Table 25: A stem and leaves diagram graphically illustrates the length of stay in 
hospital comparing HIV positive and negative groups. The ‘stem’ (first) column 
indicates the number of days admitted in hospital. The ‘leaves’ (second) column, 
indicates 1 subject per number on the leaf column according to the number of days 
admitted (row). This diagram showed that the HIV positive group was predominant 
in the 2 to 4 day period with a ‘tail’ in the 7 to 8 day period. Comparing this with the 
HIV negative group, we found a predominance in the 2 to 3 day period and no 
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prominent ‘tail’. This population was too small to prove any statistical significance (p 
<0.005%). 
  
A Box and Whisker plot analysis as well as Kruskal-Wallis test on the length of stay 
comparing the HIV positive and negative groups, did not prove any statistical 
significant differences either (refer to the analysis variance report). Analysis of the 
length of stay for the antibiotic resistant organisms, is dealt with later in this section. 
 
Analysis of Variance Report 
Response: Length of stay in hospital 
 
Tests of Assumptions Section 
 Test Prob Decision 
Assumption Value Level (0.05) 
Skewness Normality of Residuals 2.4359 0.014856 Reject 
Kurtosis Normality of Residuals 0.7835 0.433318 Accept 
Omnibus Normality of Residuals 6.5473 0.037867 Reject 
Modified-Levene Equal-Variance Test 0.0499 0.824275 Accept 
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Box Plot Section 
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Expected Mean Squares Section   X : HIV positive    No: HIV negative 
Source  Term Denominator Expected 
Term DF Fixed? Term Mean Square 
A: HIV__positive 1 Yes S(A) S+sA 
S(A) 43 No  S(A) 
Note: Expected Mean Squares are for the balanced cell-frequency case. 
 
Analysis of Variance Table 
Source  Sum of Mean  Prob
 Power 
Term DF Squares Square F-Ratio Level
 (Alpha=0.05) 
A: HIV__positive 1 5.419133 5.419133 0.97 0.330451
 0.161002 
S(A) 43 240.492 5.592837 
Total (Adjusted) 44 245.9111 
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Total 45 
* Term significant at alpha = 0.05 
 
Kruskal-Wallis One-Way ANOVA on Ranks 
Hypotheses 
Ho: All medians are equal. 
Ha: At least two medians are different. 
 
Test Results 
  Chi-Square Prob 
Method DF (H) Level
 Decision(0.05) 
Not Corrected for Ties 1 1.259881 0.261674 Accept Ho 
Corrected for Ties 1 1.332474 0.248366 Accept Ho 
 
Number Sets of Ties 8 
Multiplicity Factor 4962 
 
Group Detail 
  Sum of Mean 
Group Count Ranks Rank Z-Value Median 
HIV negative 34 739.50 21.75 -1.1224 3 
HIV positive 11 295.50 26.86 1.1224 4 
 
 
 
 
 
 
 
 
 
 
 
 
 72
Table 26: Culture Results Indicating the Frequency and Percentages of Bacterial 
Types; Percentage and Number of Penicillin and Other Antibiotics that 
Organisms were Resistant to According to HIV status. 
 Number of cases Percentage of cases Percentage of  pen 
resistance 
No. of other antibiotics 
bacteria is resistant to 
 HIV  
postive 
HIV  
negative 
HIV 
postive 
HIV  
negative 
HIV  
postive 
HIV 
negative 0 1 2 3 4 5 6 7
Normal flora 2 5 18 15           
Mixed growth 1 3 9 9           
No growth 0 9  26           
                
Anaerobes/Facul 
sp               
                
Strep viridans 
group 2 3 25 17.6           
Strep salivarius 0 1  5.9   1        
Strep sanguinis 1 0 12.5  100 Intm   1       
Strep 
parasanguanis 1 1 12.5 5.9 100 Intm 100 Intm 1 1       
Strep mitis 0 1  5.9           
                
Strep anginosus 2 6 25 11.8           
Strep constellatus 0 1  5.9   1        
Strep intermedius 1 0 12.5  100 Intm  1        
Strep anginosus 0 4  23.5   4        
Strep melleri 
1 1 12.5 5.9 0 0 
1,
1        
                
Other 
Strepoccoci 4 8 50 47.1           
Strep Thoraltensis 0 1  5.9  100 Intm 1        
Strep gordonii  1 0 12.5    1        
Strep pyogenes 0 1  5.9   1        
Strep cristatus 2 0 25            
Alpha-haemolytic 1 1 12.5 5.9 100 100 Intm 1 1       
β-haemolytic 
Strep (GF) 0 4  23.5   4        
Strep Pneumoniae 0 1  5.9   1        
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Table 26 (continued) 
 Number of cases Percentage of cases Percentage of  pen 
resistance 
No. of other antibiotics 
bacteria is resistant to 
 HIV  
postive 
HIV  
negative 
HIV 
postive 
HIV  
negative 
HIV  
postive 
HIV 
negative 0 1 2 3 4 5 6 7
Other 
Anaerobes/Facul 
sp 5 4 62.5 23.5           
Staph aureus 2 1 25 5.9 100 100 2      1  
Klebs pneumonia 
2 1 25 5.9 100 100 
1,
1 1       
E coli  0 1  5.9  100 1        
Enterobact 
cloacae  1 1 12.5 5.9 100 100 
1,
1        
 
Number of antibiotics bacteria is resistant to: HIV positive - Pink numbers 
            HIV negative - Green numbers 
 
Table 26 shows comprehensive information on the causative bacteria, indicating the 
frequency and percentage according to HIV status. Also shown, is the resistance to 
penicillin of each bacteria type as well as the number of other antibiotics that these 
bacteria showed resistance too. In the penicillin resistance column (Percentage of pen 
resistance), intermediate (Intm) resistance of the bacteria to this antibiotic is also 
indicated. In this study, only aerobic and facultative anaerobes were cultured (no 
anaerobes), because according to the Standard Operating Procedure of the NHLS 
laboratory, pus swabs with specialised carrier mediums are required for anaerobes 
cultures. This protocol was followed due to the low yields of anaerobes on pus swabs 
when specialised anaerobic carrier mediums were not used.  
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Table 27: Analysis of Penicillin Resistance (Including Intermediate Resistance) 
Comparing HIV Positive and Negative Groups 
 
 Penicillin-resistant cases HIV Positive HIV Negative 
Resistance 6 bact in 4 cases        4 bact in 4 cases 
Intermediate  3 bact in 2 cases 3 bact in 3 cases 
Total 9 bact in 5 cases 7 bact in 6 cases 
 
 
Table 27:  In the HIV positive group four cases out of eleven, were resistant to 
penicillin.  An additional two had an intermediate resistance to penicillin. In the HIV 
negative group, four cases out of thirty-four were resistant to penicillin and only three 
had intermediate resistance. Due to the small population group, statistical significance 
(p<0.005) could not be proven. However, the trend is quite evident that the HIV 
positive group has a greater tendency for resistance to the first line antibiotics. 
 
Table 28: Resistance to First-line Antibiotics, Indicating Antibiotic Management 
 
Specify change HIV Positive HIV Negative 
Clindamycin 1 0 
Cloxacillin 1 0 
Co-trimoxizole 1 0 
Gentamycin 1 0 
Vancomycin 0 1 
   
Not changed despite resistant organisms HIV Positive HIV Negative 
Was on Pen G, cloxacillin & metronidazole 0 2 
Pt on Pen G, Metronidazole  0 1 
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Table 28 indicates the number of subjects resistant to first-line antibiotics (Penicillin 
G and metronidazole) according to their HIV status. The top section of the table 
indicates antibiotics changes, and the bottom of the table indicates where antibiotics 
were not changed. Eight subjects were resistant to the first-line antibiotics. In these 
subjects (four HIV positive and one HIV negative), antibiotics were changed 
according to sensitivity results when available. The three subjects who did not have 
antibiotics changed were HIV negative. Further analysis of this group will be 
discussed later. 
 
Treatment failures occurred in one case where symptoms and clinical parameters did 
not improve. A CT scan (with contrast) indicated a retropharyngeal pus collection. 
The subject was re-operated and new drains were placed. The patient recovered well 
with no complications. 
 
Table 29 shows that eight subjects out of the total population of 45 subjects (5.63%) 
were resistant to penicillin. There were ten resistant bacteria (five different types) in 
eight subjects, averaging 1.25 organisms per subject. Length of admission was not 
correlated to the number of fascial spaces involved. The average length of admission 
of the penicillin resistant group (average 5.62 days) was the longest. When 
subdivided, the HIV positive group with penicillin-resistant organisms had an 
average length of admission of 5.75 days and the corresponding HIV negative group, 
5.50 days. 
 
Three subjects with antibiotic resistance improved despite being on the incorrect 
antibiotic (all HIV negative). Two subjects’ drains were removed, and discharged 
within 3 days prior to sensitivity results. The last subject was pregnant (first 
trimester) and had 3 fascial spaces involved (right buccal, right submandibular and 
right sublingual). Here metronidazole was omitted. She responded well to surgical 
treatment (temperature returned to normal, symptoms improved, swelling reduced 
and patient felt well). Her drains were serially removed. However, the submandibular 
drain continued to produced a little pus for six days, and was only removed on the 
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seventh day when she was discharged. It was an oversight of the treating surgeons not 
to have recorded and managed her resistant Enterobacter cloacae (she also had a 
sensitive β-haemolytic Streptoccocus). She recovered without any complications. 
 
Table 29: Types of Penicillin Resistant Bacteria according to the Number of 
Subjects, Severity (Number of Fascial Spaces), Antibiotic Change, and Length of 
Stay also indicating HIV Positive Individuals 
 
Subject 
number 
Bacteria 
 
Changed antibiotic 
 
 
No. of 
spaces 
Length of 
stay 
1 S aureus Vancomycin 2 10 
11 S aureus Clindamycin 2 7 
14 S aureus Cloxcacillin 1 5 
18 K pneumonia Gentamycin 5 3 
18 Alpha haeml Step Gentamycin 5 3 
40 K pneumonia Cotrimoxazole 1 8 
40 E cloacae Cotrimoxazole 1 8 
     
   average 2.20 average 6.60 
Subject 
number 
Bacteria 
 
Antibiotic 
not changed 
 
No. of 
spaces 
Length of 
stay 
7 K. pneumonia Pen G, Metronidazole 1 3 
21 E. coli 
Pen G, Metronidazole, 
Cloxacillin 1 2 
30 E. cloacae 
Pen G, Metronidazole, 
Cloxacillin 3 7 
      average 1.67 average 4.00 
     
Table totals     
8 subjects 10 resistant bacteria 7 antibiotic regimens total 16 total 45 
  5 bacterial types   average 2.00 average 5.62 
 
HIV positive cases - Pink numbers   
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CHAPTER 5 
 
DISCUSSION 
 
5.1 The Study Sample 
 
Within the group of fifty-one subjects with orofacial sepsis who were referred to 
either of the two Maxillo-Facial and Oral Surgery Units, six subjects did not fulfill 
the inclusion criteria. Two subjects refused to have HIV testing, three were excluded 
due to the omission of essential laboratory results (MCS or HIV results) and one 
subject was excluded due to an analysis error (the pus swab was sent to the cytology 
laboratory instead of the microbiology laboratory). The methodology used in sample 
selection was thus free of selection bias. The study sample collected over a 4-month 
period was representative of the referred population.  
 
The total study population of forty-five subjects comprised of a slightly greater 
number of males (57.78%) compared to females (42.22%). This finding was verified 
in other studies (Wood, 1978; Kannangara et al., 1980; Rega et al., 2006; Flynn et al., 
2006a). 
 
The age distribution ranged from two to 76 years with an average of 31 years. This 
wide distribution was in accordance with the findings of other studies (Kannangara et 
al., 1980; Krishnan et al., 1993; Flynn et al., 2006a). However, in the HIV positive 
group the average age of 25.45 years was much lower compared to the 32.79 years of 
the HIV negative group.  
 
In this study, 24.44% of the population was found to be HIV positive. This is 
significantly higher than the national average of 10.8% as reported by the HSRC 
Survey 2005 (Key HIV Statistics, 2008). Further analysis of HIV prevalence 
(according to province), showed that the Western Cape had the lowest rate (15.6%) in 
reported in a 2006 antenatal study (The South African Department of Health 
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Antenatal Study, 2006). In this report, it also stated that the antenatal figures were 
much higher than that of the entire population due to bias of that study sample. This 
bias was due to the exclusive selection of sexually active female subjects (higher 
transmission rates of HIV) who had unprotected sex. According to the HSRC Survey 
in 2005, the total national antenatal HIV prevalence was 29.1%, compared to the 
average of 13.3% as seen in the entire population of females above two years of age. 
The average for the entire population of males and females above two years of age 
was 10.8%, indicating a gross overestimation of antenatal prevalence figures. It is 
thus evident that the figure of 24.44% of HIV positive subjects in this study is notably 
higher than the national average of 10.8%.  
 
5.2 Materials and Methods 
 
All subjects were managed according to the same standardized treatment protocol as 
used at the two Maxillo-Facial and Oral Surgery units. The information was captured 
on a data capture sheet (Appendix 1) and recorded in duplicate. The original capture 
sheet served as the patient’s notes and a copy was retained for statistical analysis in 
this study. Variables, including admission core temperature, number of days ill prior 
to consultation and ethnicity were not recorded. This decision was based on the 
findings of Flynn et al. (2006a & b) and Amaidas (1990) which showed that the first 
two variables had no direct correlation to the severity of the infection or length of 
admission. Ethnicity was not recorded due to the current sensitivity around race 
categorisation in this country. However, the inclusion of ethnicity as a variable may 
be of value in further studies, as the burden of numerous diseases which is more 
prevalent in poorer socio-economic groups (World Health Organisation, 2004), is still 
largely racially linked in South Africa. 
 
In this study, sterile pus swabs (without a ‘carrier medium’), were used for 
microbiological analysis as per the standard protocol. The sample was obtained from 
within the wound or from the abscess (in the case of pus evacuation). Within thirty to 
forty-five minutes after collection, samples were sent (via the hospital’s tube system) 
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to the ‘sorting area’ and then to the relevant laboratories for processing. Thus, the 
time from procurement of the sample to laboratory processing, ranged from forty-five 
minutes to more than sixty minutes. According to the standard protocol of the 
microbiology laboratories (NHLS), anaerobic cultures were not conducted due the 
type of pus swab used and the length of time elapsed between sampling and 
processing (as this methodology produces low yields of anaerobic species). Literature 
showed that the ideal sampling method would be aspiration of pus via the skin and 
immediate culture of the sample (Lewis et al., 1990; Brook et al., 1991).  
 
According to Hallander et al. (2005), peri-tonsillar abscesses were sampled by 
aspiration or via pus swab after incision and drainage. In the study, the authors found 
that the aspiration method was superior as more anaerobes could be cultured with the 
least number of contaminants. They also recommended the use of a gassed-out tube 
as the transport method of choice for septic fluid, especially for anaerobes. 
 
5.3 Causes of Infection 
 
Odontogenic infections caused 63.64% (seven subjects) and 73.53% (twenty-five 
subjects) of abscesses in HIV positive and HIV negative individuals respectively. The 
second most common cause was septic fractures, causing 27.27% and 12% of the 
infections of HIV positive and HIV negative groups respectively. Most of these septic 
fractures were possibly caused by odontogenic organisms but due to the overlying 
soft tissue injuries that sometimes occurred, extra-oral organisms could also have 
been introduced. Thus, to group septic fractures as odontogenic would not be correct. 
Amaidas (1990) recorded similar findings, with 56.67% for odontogenic only causes 
and 21.67% for the tooth in the line of fracture (he grouped these as odontogenic 
infections with a total of 78.34%). The third most common cause in his study was due 
to unknown etiology (6.67%). Other studies confirm that odontogenic causes are the 
most common cause of cervicofacial sepsis (Woods, 1978; Guralnick, 1984; Morey et 
al., 1984; Boyanova et al., 2006).  
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The present study showed that the most common teeth causing sepsis were the 
mandibular bicuspids and the first and second molar teeth with 42.86% (3 subjects) 
and 44.00% (11 subjects) in the HIV positive and HIV negative groups respectively. 
The second most common causative teeth were the mandibular third molars with 
28.57% and 36.00% in the HIV positive and HIV negative groups respectively. These 
results compared with the findings of Amaidas (1990) where the third molars 
accounted for 26.09% and the other posterior teeth accounted for 44.85% of the 
cases. These findings differed from other studies (Indresano et al., 1992; Storoe et al., 
2001; Flynn et al., 2006a) which found the third molars to be the most common 
causative teeth. 
 
5.4 Spaces Involved 
 
The most common fascial spaces for the HIV positive group were the submandibular 
spaces (36%), followed by the canine and submasseteric spaces with 27% each 
(where percentages were indicated as the number of spaces per subject). This differed 
from the HIV negative group, which had buccal spaces (41%), followed by 
submandibular (33%) and canine and sublingual spaces with 18% each.  
 
Based on the severity rating by Flynn et al. (2006a), of all the above-mentioned 
spaces, only the submasseteric space would be rated as a moderate risk (2) to the 
airway. All the other spaces (submandibular, canine, buccal and sublingual), were 
classified as low risk (1). Using the severity score of Flynn et al. (2006b), there was 
almost no difference in the two groups. The author of the present study disagreed 
with the severity score assigned to the sublingual space due to its common 
association with Ludwig’s Angina. In this study, twelve subjects had sublingual space 
abscesses, of which six were part of a Ludwig’s Angina presentation. According to 
this study, it may be argued that the submandibular space abscesses (most common in 
HIV positive group) were more extensive and possibly a more severe form than the 
more localised buccal space abcesses (most common in HIV negative group). 
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However, there was no rating system known to this author that could verify this 
comparison.   
 
The author expected that more spaces would be involved in the medically 
compromised patients. However, the author was surprised to find that in the HIV 
positive group only 18% of subjects had more than one fascial space involved 
compared to 35% in the HIV negative group. Further comparison showed that with 
the infection of three or more fascial spaces, the HIV positive group had 9% and the 
HIV negative group had 18%. 
 
In the scientific literature, authors differed about the most common fascial spaces 
involved. In the study by Amaidas (1990), he listed submandibular (26.51%), body of 
the mandible (15.53%) and buccal (15.53%) spaces as the most commonly affected 
spaces. Flynn et al. (2006a), cited the pterygomandibular (60%), submandibular 
(54%) and lateral pharyngeal (43%) spaces (given as percentage of subjects affected) 
as the most frequently affected spaces. In the studies by Piecuch (1962) and Levitt 
(1976), they found that the submandibular and submasseteric spaces were the most 
common. In some studies, a distinction was made between the most common single 
space and multiple space infections. In the study by Rega et al. (2006), he found that 
the most common single space infection was the submandibular space (30%), 
followed by the buccal space (27.5%); and in the multiple space infections, the 
submental space was more common than the lateral pharyngeal spaces. According to 
his article, these findings differed from other literature in that the submandibular 
space was most frequently seen, followed by the lateral pharyngeal spaces. 
 
In the present study, the average number of spaces of the HIV positive group was 
1.45 compared to the HIV negative group with 1.76, perhaps indicating that the 
spread of infection in the HIV positive group was perhaps not as severe as previously 
theorised. A comparison of two studies and the number of spaces involved per 
subject, showed the following: Amaidas (1990): 1.72 spaces and Flynn (2006a): 3.3 
spaces (one of the highest reported in literature).  
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5.5 Blood Analysis 
 
In this study, eight of the eleven HIV positive subjects had blood and electrolyte 
results that were analysed. Seven of these patients had electrolyte and blood values 
that deviated from the normal ranges (NHLS values). Analysis of the each electrolyte 
(sodium, potassium, chloride, urea and creatinine) in the HIV positive and negative 
groups showed no statistically significant results. 
 
HIV infected subjects develop various cytopaenias that are directly correlated to the 
degree of immuno-suppression, with thrombocytopaenia possibly being diagnosed 
most often at the initial presentation (Friel and Scadden, 2009). This may be present 
at any stage of the HIV infection from asymptomatic infections to end-stage AIDS. In 
10% of patients, thrombocytopaenia may be the initial manifestation (Sloand et al., 
1992). 
 
In this study, the average values for white cell counts, haemoglobin values and 
platelet counts were normal in the HIV positive and HIV negative populations. 
Analysis of the sample according to gender, showed that three female subjects were 
aware of their HIV status, with two of these subjects in the more advanced stage of 
the disease (CD4 counts of 25 and 59). In the female HIV positive group, it was 
found that the white cell response to infection was poor with an average count of 7.31 
x 109 per litre, compared to the HIV negative group of females with 13.05 x 109 per 
litre. Haemoglobin values of 12.17 and 13.03 were found in the HIV positive and 
HIV negative groups respectively. The platelet counts of both groups were within 
normal ranges, with the average platelet count of the HIV positive group at 245.29 
compared to the HIV negative group with 357.63. A CHI – Square and Kruskal 
Wallis tests confirmed a trend (p = 0.1604). 
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5.6 Microbiology 
 
The gram stain showed that gram positive cocci were the predominant 
microorganisms with a prevalence of 90.91% and 79.4% in the HIV positive and 
negative groups respectively. The second most common were gram negative bacilli in 
the HIV positive group and gram positive bacilli in the HIV negative group. A 
statistically significant larger frequency of gram positive bacilli was seen in the HIV 
negative group (p-value = 0.0409). According to the literature by Haug (2003) and 
Robertson and Smith (2009), as well as numerous studies including Amaidas (1990), 
they found a predominance in gram positive cocci. This finding occurred in studies 
that did not use the improved methodology of sample collection and laboratory 
analysis.  
 
The culture results in this study showed the occurrence of mixed growth (15%) and 
normal flora (56%), which was probably due to contamination during the sampling 
process (either with cutaneous or oral flora). ‘No growth’ was found only in the HIV 
negative group, despite more than 80% of the study population having received 
antibiotic treatment (from referring practioners) prior to the initial consultation.  
 
A statistically significant result (p = 0.488) showed that (with > 95% confidence) no 
growth occurred in the HIV negative group only. Eight of the nine subjects with ‘no 
growth’ on culture had penicillin-sensitive microorganisms (given penicillin and 
metronidazole; or ampicillin and metronidazole). One subject was given co-
amoxiclav and metronidazole. Due to the extended spectrum of these antibiotics, no 
conclusion could be drawn about sensitivity of the microflora. 
 
Due to the improvement of sampling, transport media and culturing, studies showed 
that a mix of anaerobes and facultative anaerobes are predominant in 59 to 75% of 
cultures (Kuriyama et al., 2000). Only 20% of cultures were strict anaerobes with a 
small percentage of mixed anaerobic infections (Brook et al., 1991).  
 
 
 
 
 
 84
Table 30 compares the bacteria found in this study to those by Amaidas (1990), Haug 
(2003) and Flynnet al. (2006b) as well as the review article by Robertson and Smith 
(2009). This summary shows that in the present study, there was no culture of 
anaerobic species. In recent studies conducted in specialist microbiology laboratories, 
obligate anaerobes outnumbered facultative species by 1.5 - 3:1 (Sakomoto et al., 
1998; Khemaleelakul et al., 2002; Baumgartner and Xia, 2003). 
 
S. viridans and anginosus groups were the most common facultative anaerobes. S. 
aureus was reported as being a frequent coloniser of the oral environment (Smith et 
al., 2001) with recovery rates of 0.7 to 15 % (Brook et al., 1991; Kuriyama et al., 
2002). Higher rates have been reported in children with severe dental abscesses 
(Brook et al., 1991; Tan et al., 2001). These results compare well with the findings of 
this study. 
 
According to Brook (2004), Boyanova et al. (2006) and Robertson and Smith (2009), 
the predominant anaerobic species were Prevotella, Fusobacterium and 
Porphyromonas. In the study by Boyanova et al. (2006), it was found that the 
isolation of fusobacterium species was higher (p < 0.05) in cases of antibiotic 
treatment prior to sampling. Further findings in her study showed that 4% of the 
population cultured Bacteriodes fragilis, which was only reported as an isolated 
bacterial finding. Clostridia was an infrequently reported pathogen causing infections, 
either as a sole agent or as part of mixed flora (Robertson and Smith, 2009). In the 
review by Robertson and Smith, they found that Clostridia species have been 
identified in a few studies ranging from two to 20% of isolates. 
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Table 30: A Literature Comparison of Bacteria Causing Cervicofacial Sepsis     
          
Bacteria 3-year Retrospective Study Review 3-year Prospective Study Review  This Author's Study 
  (n=60) Amaidas, 1990 Haug, 2003 (n=37) Flynn et al. 2006 Robertson and Smith 2009 2009 
    1980 1990     HIV 
+ve 
HIV -ve 
Streptococcus viridans                                       
Total Strep: 39% 
       
26% 
         
21% 
milleri - 50% & viridans 8%       MF Facultative            
Anaerobes 
25% 17.6% 
Streptococcus  anginosus   25% 11.8% 
Beta-haemolytic Strep 12% 18%     0% 23.5% 
Peptostrepcoccus     50%       
Other Streptococci     13%   50% 23.5% 
Staphylococcus Aureus 14% 6% 7%   0.7 - 15% (> in children) 25% 5.9% 
Staphylococcus Epidermis 7.6% 8.3% 16%   4% - 65%     
Other Aerobes/ Facultative 
Species 
      50%       
Escherichia coli            
Gram -ve 
bacilli: 
25% 
    1.6%       0% 5.9% 
Klebsiella     2.2% 2.6%     25% 5.9% 
Enterobacter     1.6% 0.8%     12.5% 5.9% 
Bacteriodes (β-lactamase+ve)   Bacteriodes: 
16% 
  5.2%         
Bacteriodes (β-lactamase–ve)     3.4%         
Bacteriodes fragilis   0.5% 0.8%         
Porphyromonas species Gram -ve 
Species: 
10% 
  * Not 
reported 
                             
63% 
MF Facultative Anaerobes      
Most sudies:                 
Prevotella > Porphyromonas 
by 10 - 87%  
No Anaerobic 
Testing Performed 
Prevotella species   ** ** 
Clostridium             Not common 2 - 20 % 
pure/mixed culture 
Eikenella corrodens       7.2% 2.6%     
Haemophilis influenza       4.4% 1.7%     
Fusobacterium nucleatum           21%       
Other Anaerobic species 1.67% 
Exclusive 
Anaerobes 
not 
classified   
      88%       
Other Gram –ve species         5.2%   1%     
Key: MF = Most Frequent; * = 15 % Bacteriodes melaninogenicus (nomenclature change to Porphyromonas & Prevotella  - Haug, 1980); ** = β lactamase proucers in new nomenclature forms about 
50% of Prevotella species. 
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5.7 Newer Techniques: Molecular Techniques to Identify Flora 
 
The identification of flora was carried out using two molecular techniques. The one 
technique used molecular cloning and sequencing to identify organisms using 16srRNA 
or rDNA on uncultivatable organisms. The second method utilised PCR or DNA-DNA 
hybridisation checkerboard techniques with species-specific primers of the specific 
microbes. This has led to the identification of organisms not usually identified such as 
Treponema species. In a study by Siqueira and Roccus (2004), T. denticola species were 
found in 79% of dental abscesses. Other organisms also identified were, a Gram positive 
rod, Bulleidia extructa, Cryptobacterium curtum and Mogibacterium timidum using 
these non culture techniques (Robertson and Smith, 2009). 
 
5.8 Resistance to Antibiotics 
 
In this study, there were eight subjects with 10 strains of bacteria (5 different types) 
resistant to penicilin. Within the HIV positive group, four of the eleven subjects 
(36.36%) were penicillin-resistant and two had differing species of resistant organisms 
in the same individual. Of the thirty-four HIV negative subjects, there were four 
individuals (11.76%) who had 4 bacterial strains resistant to penicillin. 
 
This study also found bacterial strains with intermediate resistance to penicillin. The 
HIV positive group had three bacterial types in two subjects compared to the HIV 
negative where three bacterial types were found in three subjects. In summary, there 
were nine bacterial strains that showed resistance and intermediate susceptibility to 
penicillin as seen in five of the eleven HIV positive subjects (45.45%). In the HIV 
negative group, there were seven bacterial strains found in seven of the thirty-four 
subjects (20.59%). Due to the small population size of this study, the correlation 
between the HIV positive population and its higher penicillin-resistant profile can only 
be observed as a trend and not a significant finding. 
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Table 31 shows the percentage of bacterial resistance according to HIV status for 
penicillin and the number of other antibiotics that these bacteria are resistant to. 
 
Table 31:  Resistance Profile of Bacteria to Penicillin and Other Antibiotics  
 
 
 
Percentage of 
penicillin resistance 
 
 
No. of other antibiotics that bacteria are 
resistant to 
 
  
HIV 
postive 
HIV 
negative 0 1 2 3 4 5 6 
Alpha haemolytic 100 100 Intm 1 1      
Staph aureus 100 100 2      1 
Klebs pneumonia 100 100 1,1 1      
E coli   100 1       
Enterobact 
cloacae  100 100 1,1       
 
HIV positive  - Pink  
HIV negative - Green 
Intm = Intermediate Resistance 
 
The most common resistant bacteria identified were Klebsiella pneumonia and S. aureus 
as found in three subjects each. This was followed by β-haemolytic Streptococcus and 
E. cloacae, as identified in two subjects each, and E. coli was found in one subject. Of 
the three subjects with K. pneumonia, two were HIV positive and penicillin-resistant. 
The other HIV positive subject showed resistance to co-amoxiclav as well. Statistical 
analysis in this study proved that K. pneumonia was more likely to occur in the HIV 
positive population (CHI Squared = 1.1675 and p-value = 0.2799). Of the three subjects 
with S. aureus, two (HIV positive group) were resistant to penicillin, and one (HIV 
negative group) was resistant to cloxacillin, gentamycin, ciprofloxacin, erythromycin, 
clindamycin and co-trimoxazole with only sensitivity to vancomycin. Two alpha-
haemolytic Streptococcus cases were identified, with one penicillin-resistant subject 
(HIV positive group) and one with intermediate resistance to penicillin (HIV negative 
group). Two cases (one HIV positive and one HIV negative), showed penicillin-
resistance to E. cloacae, with both cases also showing resistance to co-amoxiclav, and 
one case (HIV negative group) demonstrated an intermediate resistance to cefuroxime. 
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E. coli was found in one subject (HIV negative group) and was only resistant to 
penicillin. 
 
According to the review article by Robertson and Smith (2009), resistance for S. 
anginosus is rare with 2.3% having a penicillin MIC greater than 1mgl-1 and for the S. 
viridans group, this is about 15.5%. In the studies by Kuriyama et al. (2002) and Rega et 
al. (2006), it was found that the viridans group had a susceptibility to penicillin of 77% 
and 87.1% respectively. When this organism was tested against other antibiotics for 
susceptibility, the following was reported: ampicillin (85% and 98.6%), cefazolin (96% 
and 100%), clindamycin (77% and 98.6%), erythromycin (77% and 83.4%), 
levofloxacin (92% and 98.6%) for these authors respectively. 
 
According to Haug (2003), S. aureus was the most frequently identified resistant 
pathogen. In the study by Rega et al. (2006), Staphylococci susceptibility to penicillin 
was 27.3%,  ampicillin 41.2%, cefazolin 70%, ciprofloxacin 95%, clindamycin 89.5%, 
erythromycin 75%, levofloxacin 84.2% and vancomycin 100%. In the study by Kruke et 
al. (2008), assessing the antibiotic resistance of S. aureus in cutaneous abscesses of HIV 
positive patients, he found that 93.5% were penicillin-resistant, 87% oxacillin-resistant 
(by definition methicillin-resistant S. aureus), cefazolin 84.4%, erythromycin 84.4%, and 
ciprofloxacin 52.2%. All were susceptible to co-trimoxazole, rifampicin and 
vancomycin. 
 
In the study by Boyanova et al. (2006), the resistance rates of gram negative anaerobes 
to amoxicillin was 32% and 13.5% for clindamycin as compared to the study by 
Paparaskevas et al. (2005), with a resistance rate of 81.8% for penicillin and 31.1% for 
clindamycin. Other studies showed values intermediate to these (Kuriyama et al., 2000; 
Aldrige et al., 2001; Kuriyama et al., 2001). Boyanova et al. (2006) also found that the 
resistance rates of gram negative anaerobes to metronidazole was 2.5%. The most 
common of these gram negative anaerobes was Prevotella (Robertson and Smith, 2009; 
Boyanova et al., 2006, Kuriyama et al., 2001). Penicillin resistance for Prevotella 
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species ranged from 21.7% (Boyanova et al., 2006) to more than 50% (Jousimies-Somer 
et al., 1999).  
 
The study by Boyanova et al. (2006) found that in patients treated with β-lactam 
resistant antibiotics, there was a resistance rate of 34% as compared to the rate of 14.3% 
in the case of patients who did not receive the antibiotics. In this study, the combination 
of co-amoxiclav and metronidazole showed a resistance rate of 1.3% to gram negative 
anaerobes. Ampicillin with sulbactam and amoxicillin with clavulanate were the most 
active antibiotics against anaerobes (Kuriyama et al., 2000). There were some strains of 
Peptostreptococcus and bacteriodes fragilis that showed resistance rates of 5 to 8% for 
amoxicillin and clavulanate (Aldrige et al, 2001). 
 
5.9 Length of Stay 
 
The average length of admission for the population in this study was 3.84 days. In the 
HIV positive group, the average length of stay was 4.45 days and in the HIV negative 
group, it was 3.65 days.  
 
Analysis of the penicillin-resistant group (eight subjects), showed an average length of 
admission of 5.62 days with 5.75 days for the HIV positive subjects and 5.50 days for 
the HIV negative group. In the study by Flynn et al. (2006 b), he found that subjects 
with penicillin treatment failure had an increased length of admission (p = 0.01). 
(Penicillin treatment failure was due to toxic or allergic reactions, or the development of 
necrotising fasciitis, or the failure of clinical improvement 48 hours after incision and 
drainage. 
 
In the present study, as well as the study by Flynn et al. (2006 b), no correlation was 
found between deep fascial spaces and the length of admission. Flynn also found using 
linear regression statistical testing, that a longer length of admission was associated with 
the following predictor variables; patients who required re-operation had (p = 0.01), 
Severity score (p = 0.001), number of infected spaces (p = 0.001) and time spent in 
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operating room (p = 0.007). Other studies by Dodson et al. (2001), Peters et al. (1996),  
Haug (2003) as well as  Flynn et al. (2006 b), found that white cell count, temperature 
and immune compromise correlated with increased length of stay. The immune 
compromise described in the above studies mainly consisted of medical illnesses with 
only isolated HIV cases reported. 
 
In this author’s study, using Speerman Rank Correlation, it was found that resistant S. 
aureus and sensitive or resistant E. cloacae, were positively related to increased length of 
admission (0.3444). Using the same correlation for S. parasangaunis, a negative relation 
to length of admission was found for sensitive and intermediate resistance (0.3037). This 
finding suggests that with non-resistant S. parasangaunis infections, the admission time 
would be shorter. 
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CHAPTER 6 
 
CONCLUSIONS 
 
Based on the findings in this study at the two Maxillo-Facial and Oral Surgery units in 
the Western Cape, the following conclusions can be drawn: 
 
1. Orofacial sepsis has a fair male predominance of 15.56%. 
2. The average age (31 years) of the population (young adults) is in accordance 
with other literature. However, the HIV positive group has a much lower 
average (25. 5 years). 
3. The percentage (24.44%) of HIV positive subjects with orofacial sepsis was 
higher than the national average (10.8%). (The Western Cape is the province 
with the lowest prevalence rate).  
4. The most common cause of infections was from odontogenic (71.11%). 
Septic jaw fractures were the second most common cause (15.56%). 
5. Mandibular posterior teeth (excluding 3rd molars) were the most common 
cause of odontogenic infections (43.75%) and mandibular 3rd molars were the 
second most common cause (44.38%). 
6. The most common fascial space affected in the HIV positive group was the 
submandibular space (36%), followed by the submasseteric and canine 
spaces (27% each). This compared to the HIV negative group with the buccal 
space (41%), followed by the submandibular space (33%). Thus, it appears 
that the HIV negative group may have more localised infections. 
7. The HIV positive group who had more than one fascial space involved 
comprised of 18% of the subjects; one patient was diagnosed as Ludwig’s 
Angina. The HIV negative group had 35%, of which five subjects developed 
Ludwig’s Angina (two required emergency tracheotomies). 
8. The average number of spaces involved per subject showed that the HIV 
positive group had 1.45 compared to the HIV negative group with 1.76 
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spaces infected. This result showed that contiguous spread of infection 
(number of spaces) in HIV positive subjects was not more severe. 
9. Gram stain results showed gram-positive cocci as the most dominant flora in 
both HIV positive and negative groups. Gram positive bacilli were 
statistically significantly more numerous in the HIV negative group (CHI 
Squares Test: p = 0.0409). 
10. Pre-treatment with antibiotics (by referring practioners) was associated with 
sterile infections (abscesses) in 20% of the population. No growth occurred 
in the HIV negative population with > 95% confidence interval (CHI Squares 
Test: p = 0.0488). 
11. In the HIV positive group, there was no correlation between number of 
spaces infected and electrolyte abnormalities. 
12. The average platelet count of the HIV positive group was 245.29 and the 
HIV negative group was 357.63. A trend was noted with HIV positive 
subjects having a lower platelet count. 
13. The average length of admission in hospital for the population was 3.84 days. 
The average length of admission for the HIV positive group was 4.45 days 
and for the HIV negative group, it was 3.65 days. In this study, the average 
number of spaces affected in the HIV negative group was greater but the 
average length of stay was shorter. 
14. The length of admission significantly correlated with penicillin-resistance 
(Wilcoxin Rank Sum Test: p = 0.0072). 
15. Resistant S. aureus and sensitive or resistant E. cloacae were positively 
related (using Speerman Rank Correlations) to an increased length of 
admission. A decrease in length of admission was found for sensitive and 
intermediate resistant S. parasangaunis (0.3037) infections.  
16. Penicillin resistance occurred in 17.78% (eight subjects) of the population 
and with five species of bacteria (10 strains). 
17. Of the eight subjects with penicillin-resistance, five were also resistant to co-
amoxiclav. 
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18. It was interesting to note that no subjects were found to be allergic to 
penicillin. 
19. The most common resistant bacteria was S. aureus and K. pneumonia. One 
MRSA was found and was susceptible to vancomycin. 
20. The use of culture and sensitivity tests was essential for the selection of 
appropriate antibiotics especially when faced with an increasing resistance 
profile and more severe infections. 
21. Cervicofacial infections are polymicrobial in nature and according to the 
literature, anaerobic organisms dominate with their own resistance patterns 
(not tested in this study). 
22. Due to the high percentage of bacterial resistance to penicillin and co-
amoxiclav, it may be necessary to reconsider our current antibiotic regime. 
23. A greater number of cervicofacial infections were seen in HIV positive 
subjects relative to their population prevalence rates. Added to this, was the 
higher rates of antibiotic resistance and longer hospital admissions found in 
these subjects. These findings may warrant further investigation of the 
relationship between HIV positive and negative groups with regard to 
cervicofacial sepsis. 
24. It is the opinion of the author that orofacial sepsis is seen more commonly in 
HIV infected subjects in the Western Cape. This population has greater 
numbers of resistant organisms and is more prone to complications.  
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APPENDIX I: DATA CAPTURE SHEET 
 
Data Capture Sheet                                                                       Study number: 
 
                                                                                        Yes/  has it:  √ 
                     Patient Sticker/ Write  (incl DOB) 
 
 
Previous medical History:     Retro +                        Retro -                 Uknown - 
Diabetes                                 Auto immune disease                Specify   ………………… 
 
 
Previous Surgical History: 
 
 
Allergies: 
 
Social History: 
Examination:  L – left    R  - Right 
Abscess:   Buccal Space                                          Sublingual Space 
                  Submandibular                                        Mental Space 
                  Lat Pharyngeal                                        Parotid Space 
                  Canine Space                                          Parapharyngeal 
                  Superficial Temporal                               Deep Temporal 
                  Ludwigs angina                                       Mediastinitus 
                  Cavernous Sinus Thrombosis 
Other Specify:…………………………………………………………………………………. 
 
Possible Causes:   Skin                                   Teeth (specify) …………………. 
Other……………………………………………………………………………………………. 
 
Other Forms of infection (Osteomyelitis, Necrotising Fasciitis….) 
Specify (Details)……. 
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Other notes: 
 
 
 
 
 
 
 
 
Plan: Retro test  result                                               No Consent Given   
MCS Result & FBC  & U&E: 
 
 
 
 
 
Number of Redebridements:   
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APPENDIX II: STATISTICS CAPTURE FORM 
Statistics capture form 
X : No                    √ : Yes 
Study number:                                      
                        Age                                                 Sex 
Previous medical History:     HIV+                        HIV -                 Uknown - 
Diabetes                                 Auto immune disease                Specify   ………………… 
Allergies:……………………………………. 
 
Location:                                     Left         Right                                 Left         Right 
Abscess:   Buccal Space                                            Sublingual Space  
                 Submandibular                                          Parotid Space 
                 Lat Pharyngeal                                          Parapharyngeal 
                 Canine Space                                            Deep Temporal 
                 Superficial Temporal                                Submental Space 
                 Ludwigs Angina                                       
Other Specify:………………………………………………………………………………….       
 
Possible Causes:   Skin                                   Teeth (specify) …………………. 
                                 Septic Fracture                  Unknown 
Other……………………………………………………………………………………………. 
 
Other Forms of infection: (Osteomyelitis, Necrotising Fasciitis….) 
Other Specify:…………………………………………………………………………………. 
 
HIV:    Positive:                     CD4 count:                                      Negative: 
 
MCS Results:  Mixed growth:                   Normal Flora:                          No Growth: 
Was antibiotics for No Growth           Yes            No           Types……………………………. 
Gram Stain:   Gram Positive cocci 
                      Gram Positive bacilli 
                      Gram Negative cocci 
                      Gram Negative bacilli 
 
 
 
 
 
 105
Microbiology and Antibiotic Resistance: 
 
 
 
Organisim 
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Staph aureus          
Strep 
constellatus 
         
Klebs 
pneumonia 
         
Strep 
Thoraltensis 
         
Strep salivarius          
Strep sanguinis          
Strep 
intermedius 
         
Strep gordonii          
Strep anginosus          
Alpha 
haemolytic Strep 
         
Beta haemolytic 
Strep (GF) 
         
Beta haemolytic 
Strep (C) 
         
Strep 
parasangauinis 
(Strep viridans) 
 
         
Strep pyogenes          
E coli           
Enterobact 
cloacae 
         
Beta haemolytic 
Strep (GG) 
         
 
Other 
         
S – Susceptible        R – Resistant         I - Intermedidiate 
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Abnormality in Blood Tests: 
 
Blood Parameter Blood Value  
White Cell Count  
Haemoglobin  
Platelets  
Sodium  
Potassium  
Chloride  
Urea  
Creatinine  
 
 
Number of redebridements/re- incision and drainage: 
 
Were antibiotics changed during treatment?   Yes:                       No: 
 
Specify Change…………………………… 
 
 
If patient admitted to hospital, indicate length of stay?  
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APPENDIX III: MICROBIOLOGY STANDARD OPERATING PROCEDURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
PROCEDURE FOR PROCESSING OF PUS SWABS AND PUS SPECIMENS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Any copy without original signature in red is an UNAUTHORIZED document                            
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PURPOSE 
 
To provide a uniform procedure for the culture of pus swabs and pus specimens 
 
 
INTRODUCTION 
 
The accumulation of pus, either within an abscess or exuding from a sinus tract or from a 
mucocutaneous surface, is one of the vital indicators of local sepsis.  Varying degrees of redness, 
pain, and swelling may also be present.  Exogenous wound infections include those associated 
with traumatic injury - wounds or decubitus ulcers, animal or human bites, burns, or foreign 
bodies in the skin or mucous membranes. 
 
Endogenous wounds and abscesses may be associated with appendicitis, cholecystitis, empyema, 
septic arthritis, sinusitis, cellulites, osteitis or many other internal infections.  Many of these 
infections are derived secondary to invasive procedures, surgical manipulations, or placement of 
prostheses.  Others derive from haematogenous spread from other primary sites of infection or 
by direct extension of bacterial from ruptured viscera, particularly the large intestine.  Effective 
treatment of wound infection usually includes drainage and removal of foreign bodies.  Suction 
irrigation may be helpful in resolving wound infections.   
 
Species commonly recovered from wounds include Escherichia coli, Proteus sp, Klebsiella sp, 
Pseudomonas sp, Enterobacter sp, enterococci, other streptococci, Bacteroides sp, Prevotella sp, 
Clostridium sp, Staphylococcus aureus, and Staphylococcus epidermidis (coagulase-negative 
Staphylococcus).   Care should be taken to ensure that aerosol formation is kept to a minimum 
during the processing of these specimens.   
 
 
RESPONSIBILITY 
 
All competent technical staff may process these specimens. Students may process specimens 
under supervision of qualified technologists or technicians.  
 
 
SPECIMEN 
 
Specimens received on swabs are more likely to contain colonizing organisms and normal skin 
micro-organisms than specimens obtained by aspiration with needle and syringe after 
appropriate surface decontamination. 
 
Pus swabs from:  
burns  
wound 
eye 
skin 
gall bladder  
lung, heart (post mortems) 
ANA swabs 
 
Pus from the following organs:  
Brain 
Liver 
 
 
Pus with granules  
- cover for Actinomyces (anaerobic culture) 
 
 
 
 
 
 109
EQUIPMENT AND MATERIALS 
 
Appropriate culture media 
Bacteriological loop 
CO2 incubator 
Anaerobic cabinet 
Microscope slides 
Light microscope 
 
 
PREPARATION AND STORAGE OF MEDIA 
 
All culture plates are stored at 2-8°C or on bench before use. 
 
 
METHOD 
 
Microscopic examination:  
Prepare slides for microscopy ensuring that the material is thinly and evenly spread on the slide 
surface by using the tip of the swab and rolling the swab. Care must be taken to prevent 
extraneous contamination of the specimen.  Perform Gram stain (see Gram stain SOP) 
 
Pus from brain; liver and lung are VERY important specimens. A Gram Stain must be done 
immediately and must be reported to the registrar or pathologist. N.B. remember to make slides 
with thin layer of fluid to prevent wash off when stain is made. Heat slides before inoculation to 
remove waxy layer on slide. Inoculate using swab or pipette rather than loop. Methylene blue 
stain may be helpful in differentiating cells. 
 
If culture for TB or ZN is requested, the specimen is referred to the TB lab 
If fungal culture is requested, process according to Mycology SOP. 
 
Inoculation of pus swabs and pus onto appropriate media (Date all plates!): 
Blood agar (BA) (CO2/18 - 24h) at 35ºC 
McConkey agar (McC) (CO2/18 - 24h) at 35ºC 
For pus, incubate plates for 18-48h 
Anaerobic culture for following: 
pus 
swabs in anaerobic transport media 
swabs from brain abscesses or deep wounds 
swabs from human/animal bite wounds 
Inoculate Thioglycollate broth or CMM, Nalidixic acid agar and AAM  (date all plates) 
A metronidazole (Flagyl) disc is also placed on the nalidixic plate and the AAM plate at the 
junction of the heavy inoculum 
Cooked Blood Agar (CBA)( CO2/18 - 48h) at 35 ºC 
 
 
 
 
 
 
 
 
 110
For pus specimens and if diagnosis is one of the following, add a Cooked Blood Agar plate 
incubated for 18-48h at 35 ºC: 
septic arthritis  
osteitis        
septic abortion, miscarriage etc. 
face-skin swabs in children (< 5 yr) 
All post mortem swabs 
Eye swabs 
PID= Pelvic Inflammatory Disease 
ASO =Acute salpingo-ophalitis 
 
Any specimen with a diagnosis where a growth of a Haemophilus  species, N. gonorrhoeae or N. 
meningitidis can be expected, add a CBA plate. Incubate CBA CO2 for 24 - 48h. 
 
All swabs from the liver/gall bladder area: Add a XLD plate. Incubate aerobically for 18-24h. 
 
Inoculation of Eye swabs onto appropriate media: 
BA/CBA (CO2/18 - 48h)   35ºC 
McConkey agar (CO2/18 - 48h)  35ºC 
   
On occasion we receive a BA and CBA that have been directly inoculated in the ward. Streak 
these plates again for single colonies. Incubate plates 18 - 48h CO2 at 35ºC 
 
Eye fluid: 
Inoculate as above+ wet preparation to look for Acantamoeba and Echinococcus. 
(Acantamoeba: inoculate on a “lawn” of E. coli on Page’s saline agar medium – only on request) 
 
Interpretation of results 
Clearly and accurately record all observations, smears, test results, and actions taken at each step 
of the workup. 
 
After 24 hour incubation: 
Examine the aerobic plates for evidence of growth.   
Identify all distinct colony types, and identify them according to defined laboratory protocol (see 
identification SOPs). 
Perform antimicrobial susceptibility testing on organisms from well-isolated colonies. 
All microscopic and aerobic culture results are recorded on Disalab and authorized with 
anaerobic culture results to follow.  
 
Anaerobic incubation: 
Follow anaerobic plates up for 5 days before reporting as no growth on worksheet. Identify all 
anaerobic organisms according to anaerobic SOPs and report on disalab 
 
Interpretation of culture media and the identification of probable pathogens  
The extent of testing depends on several factors, such as specimen source collection method 
(swab versus aspiration), and results of direct Gram stain   
 
Perform definitive identification and antimicrobial susceptibility testing on the following: 
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Any quantity of probable pathogens, e.g. Staphylococcus aureus, Pseudomonas aeruginosa, 
Streptococcus pyogenes 
 
Perform limited identification on the following: 
Probable skin "contaminants," which include coagulase-negative staphylococci, diphtheroids, 
viridans streptococci, and Bacillus spp., with many squamous epithelial cells and/or few to no 
pus cells on original smear  
 
Do not perform identification or antimicrobial susceptibility testing on the following: 
More than three species of intestinal flora from sites such as in intra pelvic area, decubitus ulcer, 
perianal abscess or fistula, and intestinal drainage 
   
Provide a descriptive identification of the organisms present.   
 
If one organism is predominant it should be identified and antimicrobial susceptibility testing 
should be performed. 
 
 
LIMITATION OF METHOD 
 
See SOP on uncertainty of measurement 
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REFERENCES 
 
American Microbiology Association Manual:  ISENBERG 1998. 
 
 
I, THE UNDERSIGNED, STATE THAT I HAVE READ AND UNDERSTOOD THE 
CONTENTS OF THIS SOP. 
 
DATE NAME SIGNATURE 
   
   
   
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 113
SWABS 
 
BA 35°C  CO2 
McC 35°C CO2 
Gram stain 
 
For anaerobic culture add:  
Thioglycollate broth/CMM 35°C Aerobic 
AAM (ANA)  35°C  ANA + Mz disc 
Nalidixic Acid (ANA)  35°C ANA + Mz disc 
  
 
Add: 
SS/XLD 35°C Aerobic 
 
 
EYE SWABS AND EYE FLUIDS 
 
BA/Cooked BA 35°C CO2 
McC 35°C CO2 
Gram stain 
 
Corneal scrape plates – streak for single colonies 
 
Eye fluids: 
Inoculate as above + anaerobic culture + WET PREP for Acanthamoeba and Echinococcus. 
 
If no growth or very fine growth after 24hrs, incubate a further 24 hrs 
 
 
FLUIDS/ASPIRATES 
[PD Fluid Only Gram] 
BA/Cooked BA  35°C CO2 
McC  35°C CO2 
Thioglycollate broth/CMM 35°C
 Aerobic 
AAM (ANA) 
 35°C
 ANA + Mz disc 
Nalidixic Acid (ANA)  35°C ANA + Mz disc 
 
Gram stain  
Methylene Blue stain (Pleural Fluids) 
 
Liver aspirates: Wet Prep to look for Entamoeba histolytica and Echinococcus granulosus. 
For semen, add New York City medium,  35°C  CO2 
 
If no growth or very fine growth after 24hrs, incubate a further 24 hrs 
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POST MORTEM SWABS 
 
BA/Cooked BA 35°C CO2 
McC 35°C CO2 
 
No Gram  
 
If no growth or very fine growth after 24hrs, incubate a further 24 hrs 
 
 
PUS 
 
BA/Cooked BA  35°C CO2 
McC  35°C CO2 
Thioglycollate broth/CMM 35°C
 Aerobic 
AAM (ANA) 
 35°C
 ANA + Mz disc 
Nalidixic Acid (ANA)  35°C ANA + Mz disc 
 
Gram stain 
(Methylene Blue stain) 
 
If no growth or very fine growth after 24hrs, incubate a further 24 hrs 
 
 
TISSUE 
 
Work in LAMINAR FLOW CABINET! 
BA/Cooked BA  35°C CO2 
McC  35°C CO2 
Thioglycollate broth/CMM 35°C
 Aerobic 
AAM (ANA) 
 35°C
 ANA + Mz disc 
Nalidixic Acid (ANA)  35°C ANA + Mz disc 
Gram stain  
 
If no growth or very fine growth after 24hrs, incubate a further 24 hrs 
 
 
GASTRIC BIOPSIES FOR H. PYLORI CULTURE 
 
BA  35-37°C CO2 5-7days 
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CATHETER TIPS/ CVP/ Provox 
 
Add Thioglycollate or Robertson's Meat Broth (CMM) to specimen, shake well and use standard 
4mm loop to inoculate plates. Use glass rods to streak for single colonies. 
 
BA 35°C CO2 
McC 35°C CO2 
No gram stain  
 
If no growth or very fine growth after 24hrs, incubate a further 24 hrs 
 
 
IUD 
 
Add Robertson’s meat broth (CMM) or thioglycollate broth and vortex 
Inoculate Nalidixic acid plate to screen for Actinomyces (anaerobic) x14days 
Gram stain 
Incubate broth aerobically at 35°C x 14 days, inspect daily and subculture when turbid  
 
 
HEART VALVES 
 
USE STERILE GLOVES to prevent heart valve contamination. 
 
Process in Laminar Flow Cabinet! 
 
Place valve in CMM (cooked meat broth/Robertson’s meat broth) and incubate overnight. 
No Gram stain 
Subculture next day:  
CBA (CO2/18-48h)  35ºC, 48hrs 
AAM(anaerobically)  35ºC, 48hrs – 5 days 
CMM 35ºC   Inspect daily: If turbid make gram stain and inoculate    
                                                 appropriate plates.  
      If clear, subculture again on day 14. 
 
 
 
 
 
NB!!! Add a NEW YORK CITY plate to ALL specimens where gram negative diplococci are 
seen in the gram! 
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PROCEDURE FOR PROCESSING OF FLUIDS 
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PURPOSE 
 
To provide a uniform procedure for the microscopy and culture of sterile body fluids specimens 
 
 
INTRODUCTION 
 
Infection of normally sterile body fluids often results in severe  morbidity and mortality; 
therefore, rapid and accurate microbiological assessment of these samples is important to 
successful patient management.  Most organisms infecting these sites are not difficult to culture, 
but finding a low number of commensal organisms does present an interpretative challenge.  
Any microorganism found where no resident microflora is present must be considered 
significant.  With the increased use of prostheses, immunosuppressive therapeutic regimens, and 
long-term care of individuals with chronic debilitating disease, the likelihood of true infection 
with this type of commensal organism has increased.  The final interpretation can be made by 
the pathologist in consultation with the clinician on the basis of the clinical status of the patient. 
 
 
RESPONSIBILITY 
 
All competent technical staff may process these specimens. Students may process specimens 
under supervision of qualified technologists or technicians.  
 
 
SPECIMEN 
 
Fluids (usually sterile): 
pleural fluid 
pericardial fluid 
peritonial fluid (ascites fluid) 
sinovial fluid 
eye fluid 
aspirates (liver; lung etc.) 
semen 
 
 
EQUIPMENT AND MATERIALS 
 
Appropriate culture media 
Sterile cotton swabs 
Bacteriological loop 
CO2 incubator 
Anaerobic cabinet 
Microscope slides and coverslips 
Light Microscope 
Sterile test tubes 
Centrifuge 
Sterile Pasteur Pipettes 
Rubber teat 
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PREPARATION AND STORAGE OF MEDIA 
 
All culture plates are stored at 2-8°C or on bench before use. 
 
PROCEDURE 
 
Centrifuge all fluids that are not full of pus or blood for 10 minutes at ±2000 r.p.m.  
Remove supernatant using pipette into another empty sterile tube.  
Use the sediment to inoculate all media and slides for wet preparation and Gram Stain. All 
Pleural fluids get a Gram Stain and a Methylene blue stain. 
N.B. remember to make slides with thin layer of fluid to prevent wash off when stain is made.  
Heat slides before inoculation to remove waxy layer on slide.  
Inoculate using swab or pipette rather than loop. 
If culture for TB or ZN is requested, the specimen is referred to the TB lab 
 
Wet preparation  
A wet preparation is performed on all liver and lung aspirates and eye fluids to detect parasites, 
as well as on all fluids where parasites requested. Synovial fluid is examined for uric acid 
crystals where requested. 
Using a sterile pipette, place a drop of neat fluid onto a glass slide. Coverslip and read 
microscopically using dry lens (40X or 10X). 
 
Inoculation of pleural/sinovial/pericardial, peritoneal (ascites) and semen onto appropriate 
media: 
Using a sterile pipette, gently mix  the sediment and by aspiration, transfer the sample to be 
plated.  
Drop fluid onto one quadrant of each plate medium and the remainder into the broth.   
 
Culture media (Date all plates!):  
BA/CBA (CO2/18 - 48h)                    35ºC 
McConkey agar (CO2/18 - 48h)                  35ºC 
Nalidixic Agar with metronidazole (anaerobically/ 5 days)      35ºC 
Ameliorated anaerobic media with metronidazole (anaerobically/ 5 days) 35ºC 
Thioglycollate broth or CMM (aerobic)                     ±35ºC 
 
For semen, add New York City medium   
 
 
ALL CELL COUNTS) ON SPECIMENS OTHER THAN CSF ARE DONE  BY 
HAEMATOLOGY. (IF NECESSARY MAKE COPIES OF FORM AND SPLIT 
SAMPLE)AND DOCUMENT  
 
Aspirates: 
Liver and lung aspirates: Make a wet preparationto look for Entamoeba histolytica and for 
Echinococcus granulosus. 
Other: e.g. aspirate from a fistula, aspirate from a wound. Process as for fluids. 
 
Eye fluid:  
Process as fluids 
 
 
 
 
 119
Wet preparation to look for Acantamoeba and Echinococcus. 
Acantamoeba: inoculate on a “lawn” of  E. coli – (only on request -special media required.) 
 
Interpretation of results: 
Clearly and accurately record all observations, smears, test results, and actions taken at each step 
of the workup. 
 
After 24 hour incubation: 
Examine the aerobic plates and the broth for evidence of growth.   
Identify all distinct colony types, and identify them according to defined laboratory protocol (see 
identification SOPs). 
Perform antimicrobial susceptibility testing on organisms from well-isolated colonies. 
Re-incubate blood agar and chocolate agar and broth media found to have no growth or very 
scanty growth after 24 hours. 
If primary culture media yield no growth after 24 hrs, but organisms seen on original Gram stain 
or broth turbid, do a Gram stain and subculture accordingly (see SOP on subcultures) 
 
After 48 hour incubation: 
Examine the primary plates, including anaerobic plates and subculture plates.  
If growth on plates, identify any additional organisms found on the primary or subculture media, 
and perform antimicrobial susceptibility testing. 
 
 
LIMITATIONS OF THE METHOD 
 
See SOP on uncertainty of measurement 
 
 
QUALITY CONTROL 
 
See Internal Quality Control SOP. 
 
 
 
 
 
 
 
 
 120
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PROTOCOL FOR PRIMARY IDENTIFICATION OF ANAEROBES 
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INTRODUCTION 
Most deep-seated abscesses and necrotizing lesions involving anaerobes are polymicrobial and 
may include obligate aerobes, facultative anaerobes, or microaerophiles as concomitant 
microorganisms.  These microorganisms, acting in concert with trauma, vascular stasis or tissue 
necrosis, lower the oxygen tension and the oxidation-reduction potential in tissues, and provide 
favourable conditions for obligate anaerobes to multiply.   
 
The more common endogenous anaerobic infections are listed below: 
 
- Abscess of any organ 
- Actinomycosis 
- Antibiotic-associated diarrhoea and colitis 
- Aspiration pneumonia 
- Complications of appendicitis or cholecystitis 
- Crepitant and noncrepitant cellulitis 
- Clostridial myonecrosis 
- Dental and periodontal infections 
- Endocarditis 
- Meningitis, usually after brain abscess 
- Necrotizing pneumonia 
- Osteomyelitis 
- Otitis media 
- Peritonitis 
- Septic arthritis 
- Sinusitis 
- Subdural empyema 
- Tetanus 
- Thoracic empyema 
 
It is essential to isolate and identify anaerobic bacteria because:- 
- these infections are associated with high morbidity and mortality, and 
- the treatment of the infection varies with the bacterial species involved. 
 
Isolation of anaerobes requires more exacting conditions than subsequent culture of the pure 
isolates. Therefore optimum conditions should be used for isolation. Once pure cultures are 
obtained exacting conditions are not nearly so important, but they will allow more rapid and 
more definite characterization. 
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RESPONSIBILITY  
All technicians and medical technologists who are trained to perform these test procedures are 
responsible. 
 
SPECIMEN TYPE 
pus 
swabs in anaerobic transport media 
swabs from brain abscesses or deep wounds 
swabs from human/animal bite wounds 
fluids 
tissue specimens 
IUD (for Actinomyces) 
 
EQUIPMENT 
Anaerobic jar 
Gas cylinders 
Anaerobic chamber 
Slides 
Loops 
 
MEDIA 
For primary isolation of anaerobes:   
non-selective media  AAM (appropriate anaerobic media). AAM is a Brucella agar 
supplemented with hemin, vitamin K1 and 5% laked sheep blood. It is recommended by the 
CLSI as it supports good growth of (essentially) all anaerobes.  
selective media ( Naladixic Agar) 
a broth media CMM (cooked meat media) or thioglycollate broth  (provide backup if anaerobic 
chamber fails, for enrichment for small numbers or when growth is inhibited on primary culture 
media)  
Metronidazole disc  
 
For further  identification: 
anaerobic Egg-yolk agar  
Mastring 
Anaerobic BBL crystal 
 
 
REAGENTS 
Gram stain reagents  
chromogenic nitrocephin 
Clostridium perfringens anti-toxin  
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PREPARATION AND STORAGE OF MEDIA 
All culture plates are stored at 2-8°C or on bench before use. 
 
PROCEDURE 
 
PROCESSING SPECIMENS: 
Visual examination: look for and take note of: 
blood 
purulence  
necrotic tissue 
foul odour 
sulphur granules 
 
Specimen preparation: 
Vortex grossly purulent fluids in transport vial to ensure even distribution of micro-organisms. 
Grind bone or tissue.  Robertson’s meat broth or thioglycollate broth may be added to make 
thick paste. 
Wring out swabs in liquid medium (e.g. Robertson’s meat broth or thioglycollate broth) and then 
treat as a liquid specimen. 
Centrifuge large volumes of non-purulent material and use the sediment to work with. 
 
Inoculation of media: 
aerobic media as appropriate for type of specimen 
anaerobic media , incubate in anaerobic chamber for 48hrs.  Additional periods of incubation 
may be necessary to recover some anaerobes 
thioglycollate broth/CMM, ±35°C aerobically 
Slide for Gram stain  
 
 
GRAM STAIN: 
Anaerobes can be Gram variable: 
always try to use a young culture if possible 
airdry and fix with methanol to preserve all morphology 
 
 
INTERPRETATION OF GRAM STAINS: 
large Gram positive rods with boxcar-shaped cells and no spores usually indicate C.  perfringens 
Gram negative coccobacillary forms suggest pigmenting Bacteroids or Porphyromonas group. 
 
Thin Gram negative bacilli with tapered ends suggest Fusobacterim nucleatum or 
Capnocytophaga sp. 
 
Pleomorphic pale staining Gram negative bacillary suggest Bacteroides spp. 
 
Very small Gram negative cocci suggest Veillonella spp. 
 
Long, thin branching Gram positive bacilli=?  Actinomyces or Norcardia.  A modified kinyoun 
acid fast stain should be done to confirm this. 
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AFTER 48 HOURS: 
Perform initial plate examination. 
 
Record:  colony type, noting pitting, swarming, hemolysis or “greening” of medium.  (see Table 
1) 
   
Select isolated colonies and subculture on Blood Agar or Chocolate Agar for aerotolerance 
testing (aerobic incubation) and a fresh Naladixic acid agar + metronidazole disc (anaerobic 
incubation) to ensure organism is a strict anaerobe 
 
If no growth after 48hrs, re-incubate. 
 
If no growth on primary plates on Day 5, subculture broth onto anaerobic media and incubate for 
48hrs 
. 
Table 1 
COLONY 
MORPHOLOGY 
POSSIBLE 
IDENTIFICATION 
SUPPLEMENTAL 
MEDIUM 
Agar pitting Bacteroides ureolyticus Group  
Black pigmentation Porphyromonas & Prevotella spp *EYA for lipase (Prevotella 
intermedia) 
Brick red fluorescence Prevotella intermedia Prevotella 
loeschii 
EYA for lipase 
Chartreuse fluorescence Fusobacterium EYA for lipase 
Double-zone beta hemolysis Clostridium perfringens EYA for lecithinase 
“Fried egg” Fusobacterium necrophorum EYA for lipase, 
“Greening” of medium 
Fusobacterium spp EYA for lipase 
Large with irregular margin Clostridium spp EYA for lecithinase 
“Medusa-head” Clostridium septicum  
“Molar tooth” Actinomyces spp  
Speckled Fusobacterium nucleatum  
Swarming growth Clostridium septicum Clostridium 
sordelii 
 
 
* EYA = egg yolk agar 
AFTER another 48 HOURS: 
If pure growth on Nalidixic plate, Gram stain to determine identification procedure to be 
followed. 
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IDENTIFICATION OF ANAEROBES 
 
MAST ID SYSTEM MID 8 IDENTIFICATION MASTRING 
The presumptive identification of anaerobes is done with the MID8 Identification Mastring 
method:  Fenefold et al demonstrated the use of antibiotic susceptibility patterns to characterise 
Gram negative anaerobes, and Sutter and Finegold suggested a range of 6 high strength discs for 
this purpose.  Sutter et al suggested the use of vancomycin to confirm Gram results and to 
eliminate Clostridium spp.  The Mastring is placed on a Nalidixic plate inoculated with the 
anaerobe that is to be identified. 
Strains are characterised according to the following table: 
 
 
ORGANISM ANTIMICROBIAL 
 Erythromycin Rifampicin Colistin Penicillin Kanamycin Vancomycin 
Gram negative bacilli       
Bacteroides fragillis group S S R R R R 
Prevotella melaninogenica/oralis S S S* S* R R 
Porphyromonas spp S S S S* R* S* 
Bacteroides ureolyticus S V S S S R 
Fusobacterium mortiferum/varium R R S S S R 
Other Fusobacterium spp R* R* S S S R 
Gram negative cocci S S S S S R 
Gram positive cocci 
S S R S* V S 
Clostridium spp 
S S R S* V S 
Gram positive bacilli (NSGPG) S S* R S* V S 
Peptostreptococcus anaerobius S S R S S/R S 
 
S  =  Sensitive 
R  =  Resistant 
R* =  Majority resistant 
S* =  Majority sensitive 
V  =   Variable 
If necessary identify further using the anaerobic BBL commercial kit. 
 
 
GRAM-NEGATIVE COCCI 
This includes Veillonella species, Acidaminococcus species and Megaspaera species. Veillonella 
is the only frequently encountered species of clinical importance. 
 
 
 
 
 
 127
Identification: 
See Mastring reactions.   
 
GRAM NEGATIVE BACILLI 
Anaerobic gram-negative bacilli are the most commonly encountered anaerobes in clinical 
specimens, with Bacteroides fragilis isolated more frequently than any other anaerobes.  The B. 
Fragilis group produces ÿ-lactamase and includes species resistant to many antibiotics 
commonly used to treat anaerobic infections.   
This group includes Bacteroides species Porphyromonas species, Prevotella species and 
Fusobacterium species.  These species are identified on the basis of colonial and cellular 
morphology, pigment production, susceptibility to antibiotic discs and certain rapid biochemical 
characteristics.  Gram-negative anaerobic bacilli are the most commonly encountered anaerobes 
in clinical infections.   
 
Pigmenting anaerobic gram-negative bacilli: 
These may be divided into those that are saccharolytic i.e. Prevotella species and those that are 
asaccharolytic i.e. Porphyromonas species.  Pigmentation is due to protoheme production. 
 
Fusobacterium species 
Fusobacterium are commonly involved in serious infections in various body sites and have been 
frequently isolated from blood cultures.  Fusobacterium necrophorum is a very virulent 
anaerobe that may cause severe infection. 
 
Identification of Gram negative bacilli: 
See Mastring reactions 
 
GRAM POSITIVE COCCI 
The anaerobic cocci are frequently encountered in the clinical laboratory in blood cultures and 
other body fluids and in a wide variety of wound and abscess specimens.  Except for 
Peptococcus niger all former species of the genus Peptococcus were transferred to the genus 
Peptostreptococcus. 
 
Identification: 
See Mastring reactions 
 
GRAM-POSITIVE BACILLI 
Anaerobic gram-positive bacilli of human clinical relevance are divided into two distinct groups 
one genus of endospore formers (Clostridium species) and genera of non-sporeformers.   
Clostridium species can cause acute, severe or chronic infections.  Some are highly pathogenic 
or toxigenic. 
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1. SPORE FORMING BACILLI 
The anaerobic gram-positive, spore forming bacilli belong to the genus Clostridium.   
 
Certain clostridia for example: C tertium, C inulinum, C durum and C carnis are aerotolerant and 
form colonies on 10% horse blood agar incubated in a 5% to 10% CO2 (i.e. in microaerophilic 
conditions). 
 
The following criteria are used to determine whether an isolate is an aero-tolerant Clostridia 
species or a facultatively anaerobic Bacillus species. Aerotolerant Clostridia will rarely form 
spores when grown aerobically and are catalase negative, whereas Bacillus species will rarely 
form spores when grown anaerobically and are catalase positive.  To demonstrate spores, Gram-
stained preparations are usually sufficient. 
  
2. GRAM-POSITIVE NON-SPORE FORMING BACILLI 
Included in this group are members of the following genera: 
Actinomyces 
Bifidobacterium 
Lactobacillus 
Mobiluncus 
Propionibacterium 
Eubacterium 
 
The nonsporeformers are infrequently significant and usually cause chronic disease.  Many of 
these nonsporeformers are resistant metronidazole. 
 
 
In cellular morphology members of these genera are usually pleomorphic gram-positive to gram-
variable rods.  If these organisms are observed on a direct gram smear of clinical material, 
cultures may require incubation for up to 2 weeks for the organisms to grow. 
 
 
 
IDENTIFICATION 
See Mastring reactions. If necessary, identify on anaerobic BBL crystal. 
If  Clostridium spp. according to Mastring results, put up egg- yolk agar with antitoxin (Nagler 
reaction) if available.  
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NAGLER REACTION 
For this reaction use an egg-yolk medium, and smear one half of the surface with antitoxin 
(antitoxin serum made up of C perfringens and C novyi).  The culture is then streaked in a single 
line across the plate at a right angle to the antitoxin.  
 
The toxin lecithinase produces a precipitate (opalescence) around the growth in the line of streak 
in the absence of antitoxin, but is inhibited on the half of the plate with antitoxin.  A positive 
control organism of  
C perfringens should also be included in the test. 
  
Cloudy (opaque) zone in medium around colony  = lecithinase positive 
Oily irridescent sheen over and immediately around growth = lipase positive. 
An opaque zone may be present under the irridescent sheen. 
 
C perfringens produces colonies showing double zones of haemolysis and the Nagler test is 
positive.  A more recently described test, the reverse CAMP test is specific to C perfringens and 
reveals enhanced haemolysis of group B streptococci. 
 
TEST ALL ANAEROBES FOR THE PRODUCTION OF -LACTAMASE  
ÿ-lactamase testing using Nitrocefin 
Chromogenic nitroceflin solution should be used.  Add a drop of solution onto glass slide and 
smear inoculum directly onto spot.  Should be read after 10 minutes. 
Pink colour = positive 
No colour = negative. 
 
LIMITATION OF METHOD 
See SOP on uncertainty of measurement 
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